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Summary 
Haematopoietic stem cells (HSCs) reside in specialized microenvironments in the 
bone marrow (BM) called “niches”. BM HSC niches comprise different stromal cell 
types that directly or indirectly contribute to maintain and regulate HSCs and, in turn, 
haematopoiesis.  
In the last two decades, multiple studies have revealed the importance of numerous 
BM stromal cell types as modulators of different HSC functions, like 
migration/trafficking and proliferation/quiescence. Many studies have suggested 
that specific niches close to the bone surface (endosteal) or around sinusoids 
(perisinusoidal) can regulate distinct HSC states. How these different niches 
cooperate to coordinate various HSC activities according to organismal demands 
remains unclear. 
In this thesis, novel neural signals have been found to regulate different HSC 
functions in spatially separated niches during circadian time cycles. Central 
cholinergic signals from the parasympathetic nervous system antagonise BM 
sympathetic noradrenergic activity during the nocturnal phase. Cholinergic inhibitory 
signals indirectly diminish 3-adrenergic signalling in perisinusoidal niches, 
reducing HSC egress at a specific circadian time. Cholinergic signals also appear 
to contribute to bone remodelling via unknown mechanisms. In addition, a specific 
type of sympathetic neuron that switches from noradrenergic to cholinergic fate 
during the first postnatal weeks has been identified in endosteal niches. Sympathetic 
cholinergic fibres might promote BM colonisation of HSC through Cxcl12 induction 
in immature BM niches. In adult mice, sympathetic cholinergic innervation targets 
bone-associated nestin+ BM stromal cells and promotes Cxcl12 expression, 
favouring HSC quiescence and long-term maintenance. 
In summary, neural signals from both branches of the autonomic nervous system 
cooperate to orchestrate and integrate different HSC features in a spatiotemporal 
context. While sympathetic noradrenergic signals activate HSCs and favour their 
trafficking, parasympathetic and sympathetic cholinergic activity promote HSC 
maintenance signals that counterbalance the first. This precise regulation might help 
to adjust stem cell functions to meet physiological requirements. 
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Resumen 
Las células madre hematopoyéticas (HSCs) residen en microambientes 
especializados de la médula ósea llamados “nichos”. Los nichos de HSCs de la 
médula ósea engloban a las células estromales y moléculas que directa o 
indirectamente contribuyen a mantener y regular las HSCs y, así, la hematopoyesis. 
En las dos últimas décadas, múltiples estudios han demostrado la importancia de 
distintos tipos de células estromales como reguladores de las propiedades de las 
HSCs, como su migración/tráfico y su proliferación/quiescencia. Muchos de estos 
estudios han sugerido que determinados nichos próximos a la superficie ósea 
(endostiales) o alrededor de los sinusoides (perisinusoidales) están especializados 
en regular distintas funciones de las HSCs. Pero aun queda por aclarar como esos 
nichos pueden coordinarse entre sí de acuerdo a las necesidades del organismo. 
En esta tesis se han encontrado nuevas señales neurales capaces de regular 
diferentes funciones de las HSCs en nichos separados y en distintos momentos del 
día. Señales parasimpáticas colinérgicas centrales antagonizan la actividad 
simpática noradrenérgica durante la noche. Estas señales disminuyen la 
señalización adrenérgica 3 en nichos perisinusoidales, y reducen la salida 
circadiana de las HSCs hacia la sangre. Además, las señales colinérgicas parecen 
contribuir al remodelado óseo por vías aun desconocidas. Por otra parte, en los 
nichos endostiales se ha identificado un tipo específico de neurona simpática que 
cambia de fenotipo noradrenérgico a colinérgico. Estas fibras podrían contribuir a 
la colonización de la médula por parte de las HSCs durante el desarrollo postnatal 
al estimular la producción de Cxcl12. En estadío adulto, estas fibras inervan algunas 
células estromales nestina+, incrementando su expresión de Cxcl12 y favoreciendo 
la quiescencia y mantenimiento a largo plazo de las HSCs. 
En resumen, este trabajo sugiere que la señales neurales procedentes de ambas 
ramas del sistema nervioso autónomo coordinan distintas funciones de las HSCs 
en un contexto espacio-temporal. Mientras que las señales simpáticas 
noradrenérgicas activan a las HSCs y estimulan su tráfico, la señalización 
parasimpática y simpática colinérgica promueve señales de mantenimiento que 
equilibran las primeras. Esta regulación precisa podría ayudar a ajustar las 
funciones de las células madre de acuerdo con las necesidades fisiológicas. 
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1 Introduction  
1.1 The haematopoietic system 
Haematopoiesis - the production of blood cells – primarily takes place in the bone 
marrow (BM), which is located inside the bones (Fig. 1). Two types of BM have been 
described: red marrow and yellow marrow. All haematopoietic cells (including 
erythrocytes and leukocytes) and platelets ultimately arise from haematopoietic 
stem cells (HSCs) allocated in the red marrow, whereas the yellow marrow contains 
fat tissue (adipocytes). The red marrow represents the BM at birth, but starts to 
decrease with age, when the yellow marrow becomes predominant. As a 
consequence, the efficiency of haematopoiesis decreases with ageing and can 
eventually lead (under pathological conditions) to BM failure. 
 
Figure 1. The BM is the main haematopoietic organ and is located in the bone 
cavity. A, Murine tibia and femur are two long bones with high BM content. B, Azan 
trichrome staining of a 10 µm femur section. C, Scheme illustrating the complexity 
of the BM, which includes many different types of haematopoietic and stromal cells. 
1.2 Bone marrow stem cell niches 
The HSC is one of the best characterized adult stem cell types, partly due to the fact 
that it was the first one discovered in the early 1960s. HSCs have the capability to 
self-renew and differentiate to progenitors cells, which in turn give rise to committed 
blood cells of multiple “lineages”. Under homeostatic conditions, many HSCs exhibit 
a quiescent state, ensuring the long-term repopulation (LTR) of blood cells 
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throughout life (Cheshier, Morrison, Liao, & Weissman, 1999). During differentiation, 
a hierachy of haematopoietic cells with progressively decreasing self-renewal and 
increasing proliferative capacity is established. However, intense research over the 
last decades has suggested that HSCs are heterogeneous. The SLAM family 
markers CD150 and CD48, together with many other markers, have been used to 
identify distinct subpopulations of HSCs (Fig. 2A) (Kiel et al., 2005; Oguro, Ding, & 
Morrison, 2013). Whereas intrinsic mechanisms controlling HSC quiescence, self-
renewal and differentiation have been investigated with more detail, the role of 
external cues in regulating haematopoiesis is still an emerging field of research.  
HSCs and haematopoietic cells are surrounded by bone, cartilage and multiple 
types of bone marrow stromal cells. Some of these stromal cells share markers and 
in vitro features with mesenchymal stem cells isolated from different tissues. These 
are the BM-derived mesenchymal stem and progenitor cells (BMSCs). In contrast 
to the HSC hierarchy, in which several populations of haematopoietic stem and 
progenitor cells (HSPCs) have been defined and are broadly accepted in the field, 
BMSC lineages are still poorly understood (Fig. 2B) (Bianco, Robey, & Simmons, 
2008). Research in the past few years has characterised BMSCs by combining in 
vitro assays with in vivo fate-mapping experiments. These studies have shed light 
on different BMSC populations that can be identified with specific markers (Chan et 
al., 2015; Kunisaki et al., 2013; Mendez-Ferrer, Michurina, et al., 2010; Zhou, Yue, 
Murphy, Peyer, & Morrison, 2014).  
BMSCs and HSCs have originally been described, in the context of regeneration, 
as the cells responsible for BM reconstitution after mechanical depletion of the 
marrow cavity (Patt & Maloney, 1975). Since Friedenstein et al. identified BMSCs 
as fibroblastic-colony-initiating cells giving rise to the haematopoietic stroma in 
culture (Friedenstein, Chailakhjan, & Lalykina, 1970), multiple indications have 
pointed at the important role of BMSCs in supporting haematopoiesis through direct 
and indirect mechanisms. Dexter et al. proposed a method of obtaining murine long-
term cultures of BMSCs which maintain haematopoiesis in vitro (Dexter, Wright, 
Krizsa, & Lajtha, 1977). Although the concept of the stem cell niche was first 
introduced three decades ago in the haematopoieitc system (Schofield, 1978), only 
very recently experimental evidence has been gathered which demonstrates the 
critical BMSC role in the HSC nice. 
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Besides BMSCs, other haematopoietic and non-haematopoietic cells regulate 
HSCs directly or indirectly. This include osteoblasts, macrophages, 
megakaryocytes, endothelial cells, T-regulatory cells, peripheral neurons and 
Schwann cells (Fig. 3) (Morrison & Scadden, 2014). 
 
Figure 2. HSC (A) and BMSC (B) hierarchies have been determined based on 
functional assays and on surface membrane antigen expression 
(immunophenotype). A, Different surface membrane antigens have been used to 
distinguish between long-term HSC (LT-HSC) and different multipotent progenitor 
(MPP) populations including intermediate (IT), short-term (ST) and lymphoid-primed 
multipotent progenitors (LMPP). B, Specific BMSC populations have been well 
characterised but the existence of subpopulations and their relationships is currently 
subject of debate and study in the field. 
1.2.1 Osteoblasts 
Osteoblasts are short-lived bone-forming cells. The ones in contact with the bone 
matrix are also named “bone-lining” cells, which can over time be trapped in the 
bone matrix and become osteocytes. HSPCs have initially been detected close to 
the inner bone surface (“endosteum”). For this reason bone-lining osteoblasts have 
been proposed to play an active role in regulation of haematopoiesis (Gong, 1978; 
Lord, Testa, & Hendry, 1975; Nilsson, Johnston, & Coverdale, 2001). Calvi et al. 
provided the first in vivo evidence of osteoblasts as candidate HSC niche cells that 
control endosteal HSCs through Notch signalling (Calvi et al., 2003). At the same 
time, BMP signalling in bone-lining osteoblasts appears to regulate the BM HSC 
niche size (Zhang et al., 2003). Angiopoietin-1 (Ang1) produced by osteoblasts and 
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other stromal cells as well as HSC contributes to Tie-mediated HSC quiescence and 
endosteal localization (Arai et al., 2004; Zhou, Ding, & Morrison, 2015). 
Thrombopoietin (Tpo)/Mpl signalling has also been proposed to regulate primitive 
HSCs in osteoblastic niches (Yoshihara et al., 2007). However, it seems that 
megakaryocytes, instead of osteoblasts, might be the major source of Tpo in the 
BM (Nakamura-Ishizu, Takubo, Fujioka, & Suda, 2014). 
Osteopontin (Opn), produced by osteoblasts of the endosteal bone surface, has 
been proposed as a relevant component of the osteoblastic HSC niche by attracting 
and retaining HSPCs, while inhibiting HSC proliferation (Nilsson et al., 2005). 
In summary, these studies highlight the osteoblast as one of the first non-
haematopoietic defined cell types that can regulate HSCs. Later studies have 
suggested that osteoblasts have a more prominent role in the regulation of lymphoid 
progenitors, although they participate in the regulation of HSC traffic. 
Contemporarily, BMSCs have been increasingly recognised as key HSC niche cells. 
1.2.2 BMSCs 
Studies both in human (Sacchetti et al., 2007) and murine (Mendez-Ferrer, 
Michurina, et al., 2010) BMSCs suggested the possibility that two different somatic 
stem cell types (haematopoietic and mesenchymal stem cells) share the same 
niches in the BM. The intermediate filament protein nestin has been used to identify 
in Nestin-gfp transgenic mice this BMSC population with high fibroblastic colony-
forming-unit (CFU-F) activity and self-renewal capacity in serial transplantations. 
Nestin+ BMSCs have been shown to express high levels of HSC maintenance 
genes, like Cxcl12 (Nagasawa et al., 1996), Stem cell factor (Scf) and Ang1. In 
addition, sympathetic nervous system stimulation or nestin+ BMSC depletion 
reduces the expression of HSC maintenance genes resulting in HSC activation and 
trafficking (Mendez-Ferrer, Michurina, et al., 2010). 
Shortly thereafter, Omatsu et al. also concluded that the stromal HSC niche 
population in the BM that they had previously characterised by a reticular shape and 
high expression of Cxcl12 contained BMSC-like cells. These cells are called Cxcl12-
abundant reticular (CAR) cells and are highly enriched in mesenchymal progenitor 
activity. Similar to nestin+ BMSC depletion, ablation of CAR cells reduces HSPC 
numbers and impairs HSC function (Omatsu et al., 2010; Sugiyama, Kohara, Noda, 
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& Nagasawa, 2006), albeit larger depletion of stromal cells using the CAR model 
also causes loss of multiple haematopoietic progenitors. Subsequent studies have 
shed more light on the importance of Cxcl12-expressing cells in HSPC regulation; 
however, the role of different Cxcl12-expressing cells has become controversial 
depending on their source and location. While Cxcl12 expression in osteoblasts has 
been shown to be relevant for B-cell lymphopoiesis and progenitor retention in the 
BM, perivascular Cxcl12 has been reported to directly target HSCs (Ding & 
Morrison, 2013; Greenbaum et al., 2013). Part of the controversy might be explained 
by partial overlap of stromal cell populations identified with different markers and 
differences of cell-type specificity and recombination efficiency, depending on the 
Cre line used. 
All these studies have highlighted the Cxcl12-Cxcr4 axis as one key molecular 
pathway in HSPC regulation by BMSCs. Rac GTPases, activated by Cxcl12 in 
nestin+ perivascular BMSCs, have been shown to control several aspects of HSC 
maintenance (Ciuculescu et al., 2015; Sanchez-Aguilera et al., 2011). However, 
other signals different from Cxcl12 also importantly regulate HSCs. Long-term 
activation of Gs signalling in osteoblastic cells negatively affects HSC maintenance 
(Adams et al., 2009; Schepers, Hsiao, Garg, Scott, & Passegue, 2012), and Wnt 
signalling has been involved in the survival, self-renewal and differentiation of 
HSPCs (Florian et al., 2013; Reya et al., 2003).  
In the last few years intense efforts to characterise primary BMSCs have provided 
different markers for partially-overlapping cell populations (Fig. 2B). Perivascular 
leptin receptor (Lepr) positive and Scf-expressing cells contain HSC niche-forming 
BMSCs (Ding, Saunders, Enikolopov, & Morrison, 2012). Whereas Lepr mainly 
marks Nes-GFPlo cells associated with sinusoidal vessels, the Frenette laboratory 
has proposed NG2+ cells as a Nes-GFPhi BMSC population forming an arteriolar 
HSC niche. Depletion of NG2+ cells triggers HSPC proliferation and dampens HSC 
LTR-capacity in vivo (Kunisaki et al., 2013). This study has been disputed by the 
Morrison laboratory, which has found that Lepr+ cells contain all BMSC populations 
(Zhou et al., 2014). However, it remains unclear to which degree BMSCs labelled in 
a transgenic LeprCre;tdTomato mouse model overlap with other BMSC 
subpopulations. Lepr+ cells and HSPCs themselves have been proposed as the 
major BM source of Ang1 required for BM HSC niche regeneration. These findings 
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are in contrast to previous studies suggesting that osteoblasts are major Ang1-
producing cells (Arai et al., 2004; Zhou et al., 2015). Recently, the relevance of each 
factor produced by different cells in the HSC niche has been investigated. Whereas 
HSCs mainly depend on Scf produced by  Lepr+ Nes-GFPlo BMSCs cells, HSCs 
mainly require Cxcl12 produced by Lepr- Nes-GFPhi NG2+ BMSCs (Asada et al., 
2017). Nevertheless, since all these cell populations express these factors, it 
remains unclear why they are biologically relevant only in one niche, but not in the 
other. 
Human BMSCs have been identified using the melanoma cell adhesion molecule 
(MCAM; also known as CD146) as a marker that highly enriched BMSCs and cells 
with HSC-niche features (Sacchetti et al., 2007). However, the Scheding group has 
also found CD146-CD271+ BMSCs preferentially associated with the endosteum 
(Tormin et al., 2011). A recent study has demonstrated that CD146+ BMSCs support 
long-term persistence of human lymphomyeloid HSPCs through cell-contact 
dependent Notch signalling (Corselli et al., 2013). CD105 (endoglin) is another 
surface antigen used to label human BMSCs (Lv, Tuan, Cheung, & Leung, 2014). 
Along these lines, non-adherent cultures of BMSCs in enriched medium that 
favoured their self-renewal (mesenspheres), originated from CD146+CD105+nestin+ 
cells, promote HSC expansion. Indeed, increased long-term human haematopoietic 
engraftment in serial transplantations, from HSCs previously expanded in the 
presence of mesenspheres, has highlighted the relevance of primitive BMSCs in 
HSC maintenance (Isern et al., 2013). Similarly, PDGFr+CD51+ nestin+ cells have 
been shown to highly enrich for BMSCs capable of HSC support (Pinho et al., 2013). 
In contrast, adult human BMSCs are enriched in the PDGFr-CD271+ cell fraction 
(Li et al., 2014). Therefore, ressembling CD34 expression on HSCs, murine and 
human BMSCs also differ in marker expression. Overall, significant advances over 
the last years now allow for the isolation and prospective identification of primary 
BMSCs. These studies have also highlighted the relevance of primitive BMSCs in 
the HSC niche. 
1.2.3 Endosteal vs perisinusoidal BM niches 
Beyond the ongoing debate about different markers to identify BMSCs with HSC 
niche function, the distribution of BMSC subpopulations within the BM cavity and 
 Introduction 
 
 
9 
 
their differential impact on different HSPC populations/functions is a topic of intense 
research in the field. 
To address this question it is essential to identify HSCs in the BM. HSCs have been 
immunophenotypically defined based on the expression of SLAM family receptors 
by the Morrison’s laboratory. The majority of primitive HSCs are enriched in the 
Lineage-Sca1highckit+CD34-CD48-CD150hi population, which is more abundant 
around sinusoids in the BM, defined as perisinusoidal niches (Kiel et al., 2005; 
Oguro et al., 2013). However, small subsets of HSPCs were initially found by others 
in close association with the bone, near the endosteal surface of the diaphyseal 
bone, but more abundantly in the trabecular BM. This, together with the fact that the 
first in vivo studies suggested a relevant role for osteoblasts in the regulation of HSC 
quiescence, has prompted the idea that endosteal niches harbour quiescent HSCs 
(Arai et al., 2004; Nilsson et al., 2005; Yoshihara et al., 2007). 
Scf-expressing Lepr+ cells are located adjacent to sinusoidal endothelial cells in the 
highly vascularized area in the central part of the BM. Interestingly, Scf deletion in 
endothelial or perivascular Lepr+ cells drastically reduces HSCs numbers in the BM 
(Ding et al., 2012). Recent studies originated from the angiogenesis field have 
characterised the BM vasculature and identified markers for vessel subtypes 
(sinusoids, endosteal arterioles and arteries) with different functions and associated 
perivascular cells. The grade of vessel permeability, highly conditioned by the 
surrounding perivascular cells and extracellular matrix, has been suggested to 
regulate HSC quiescence. While less permeable arterial-like vessels contribute to 
keep HSCs quiescent, the higher permeability of sinusoids favours HSPC activation 
and trafficking (Itkin et al., 2016; Kusumbe et al., 2016). However, quiescent HSCs 
are abundant in the sinusoids (Acar et al., 2015), where other mechanisms might 
promote HSC quiescence. For instance, megakaryocytes, which are very abundant 
near sinusoids, have been proposed to promote HSC quiescence by secretion of 
Pf4/Cxcl4, transforming growth factor β (Tgf-β), Tpo and Clec-2 (Bruns et al., 2014; 
Nakamura-Ishizu et al., 2014; Zhao et al., 2014). 
The improvement of imaging techniques has allowed tracing single HSCs in their 
niches. Taking advantage of high-resolution confocal two-photon intravital imaging, 
some authors have found enrichment of primitive HSCs in endosteal areas, arguing 
for a non-random distribution of  transplanted HSCs in the BM (Nilsson et al., 2001). 
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This different HSC location has been linked to HSC differentiation status, with 
primitive cells located closer to bone (Lo Celso et al., 2009). Furthermore, HSCs 
tend to home to endosteal areas in irradiated mice, from where they expand to 
regenerate the damaged BM (Xie et al., 2009).  
Previous studies have suggested that functionally distinct HSCs (quiescent and 
active) occupy different BM niches (endosteal and perisinusoidal, respectively). 
Interestingly, HSCs can reversibly switch between dormant and activated status 
based on their needs during homeostatic conditions or after haematopoietic stress 
(Wilson et al., 2008). More recently, Acar et al. has used tissue clearing techniques 
to perform deep confocal imaging of the BM. In contrast to previous studies, they 
have reported that most of HSCs (independently if they were active or inactive) are 
located close to Lepr+ BMSC in perivascular niches and distant from endosteal 
niches (Acar et al., 2015). It has to be noted that sinusoids occupy over 90% of the 
BM volume of long bones, and it remains possible that the much lower number of 
endosteal HSCs might be especially important under stress/regenerative settings, 
as suggested from the studies in lethally-irradiated mice, in which the sinusoids are 
largely damaged, whereas endosteal vessels are spared (Hooper et al., 2009). 
Other studies have recognised the relevance of both niches. CAR cells, which are 
in contact with most HSCs, are distributed around sinusoidal endothelial cells but 
also near the endosteum. Thus, Cxcl12-Cxcr4 signalling seems to regulate both 
vascular and endosteal niches in the murine BM (Sugiyama et al., 2006). 
Importantly, the original dichotomy between endosteal and vascular niches is no 
longer valid because the endosteum is also highly vascularised. Endosteal vessels 
have been found near N-cadherin+ pre-osteoblastic cells (Xie et al., 2009). More 
recently, a new BM vessel subtype formed of CD31highEndomucinhigh endothelial 
cells has been described. These vessels, called transition zone (TZ) vessels as they 
connect lowly permeable arterioles with highly permeable sinusoids and have mixed 
properties, are exclusively found in endosteal areas and in the growth plate 
(Kusumbe, Ramasamy, & Adams, 2014). 
However, despite many advances in the understanding of the BM HSC niche in the 
last years (Boulais & Frenette, 2015; Ehninger & Trumpp, 2011; Kiel & Morrison, 
2008; Morrison & Scadden, 2014), the impact of each niche on haematopoietic fate 
 Introduction 
 
 
11 
 
and its precise composition are not fully clear. In fact, it is reasonable to argue that 
different types of niches co-exist and house HSCs with different features and 
functions. Another interpretation supports the concept that HSCs circulate between 
different niches according to the needs required in a dynamic system (Trumpp, 
Essers, & Wilson, 2010) (Fig. 3). 
 
Figure 3. HSCs reside in different specific BM microenvironments called 
“niches”. In homeostasis HSCs are in a dynamic balance in which distinct niches 
provide signals that regulate HSC behaviour and function. However, in stress 
situations this balance is altered to meet the needs and recover homeostasis. 
1.3 The autonomic nervous system 
In addition to the contribution of mesenchymal stromal elements, other cells with a 
neural crest origin control the BM HSC niche. The autonomic nervous system has 
been proposed to play an important role in regulating HSCs. 
The peripheral nervous system connects the central nervous system (CNS, brain 
and spinal cord) with the target organs in the periphery. The peripheral nervous 
system is divided into the somatic nervous system and the autonomic nervous 
system (ANS). The somatic nervous system is responsible for voluntary movements 
of the body and is comprised of motoneurons that innervate the skeletal muscle to 
activate muscle contraction and sensory fibres that innervate the skin to transmit 
sensory signals to the CNS. 
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The ANS is responsible for modulating involuntary actions that ensure proper 
functioning of our body and contributes to its homeostasis. Therefore, the ANS 
innervates multiple internal organs such as the heart to control the heart rate or the 
bladder to influence the urination process. Moreover, haematopoietic organs, such 
as the BM or the spleen, are innervated by the ANS (Calvo, 1968). 
The ANS is divided into two branches: the sympathetic nervous system (SNS) and 
the parasympathetic nervous system (PNS). SNS and PNS are both structured as 
“two-step efferent pathways” containing ganglions in which a preganglionic neuron 
forms a synapse with a postganglionic fibre that eventually innervates the peripheral 
organ (Richins & Kuntz, 1953). 
The sympathetic branch, which has its preganglionic origin in the thoracolumbar 
region of the spinal cord, has traditionally also been called “noradrenergic”. The 
parasympathetic branch, which originates from cranio-sacral areas, has been 
described as “cholinergic”. This alternative nomenclature is based on the type of 
neurotransmitter released by postganglionic terminals in each system: 
catecholamines (adrenaline/noradrenaline) in the SNS, and acetylcholine in the 
PNS. However, acetylcholine can also act as preganglionic neurotransmitter in both 
branches of the ANS (Burnstock, 1981). 
Although classical concepts present both branches with opposing effects, many 
exceptions have been described, which contradict this general rule. Yet, 
sympathetic signalling is associated with rapid activating responses, while 
parasympathetic signals are more related to slow, dampening responses. In the 
context of the immune response, the SNS triggers the inflammatory response at 
initial steps of an injury, while the PNS activates anti-inflammatory pathways at the 
end of the process to resolve inflammation (Olofsson, Rosas-Ballina, Levine, & 
Tracey, 2012; Pongratz & Straub, 2014).  
Despite recent studies on the parasympathetic innervation of haematopoietic 
organs, little is known about the possible relevance of the PNS as regulator of 
haematopoiesis beyond its anti-inflammatory properties. However, the SNS has 
been more extensively studied and associated with multiple physiological 
haematopoietic functions (Fig. 4). 
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Figure 4. Neural regulation of haematopoietic organs. SNS signalling modulates 
HSC trafficking and maintenance in the BM by activating β-adrenergic receptors in 
BMSCs and HSCs. PNS anti-inflammatory signalling has been described in the 
spleen, but the cholinergic contribution to the BM has not been explored. 
1.3.2 Sympathetic innervation of haematopoietic organs 
Sympathetic postganglionic terminals innervate haematopoietic organs where they 
release catecholamines as neurotransmitters. Catecholamines are synthesized 
from tyrosine, which is first transformed to dihydroxyphenylalanine by tyrosine 
hydroxylase (TH), and then converted to dopamine. Dopamine is loaded into 
vesicles inside sympathetic terminals and transformed into noradrenaline by 
Dopamine-b-hydroxylase (DBH) (Nagatsu, Levitt, & Udenfriend, 1964). Although 
noradrenaline is the main neurotransmitter released by sympathetic fibres in 
haematopoietic organs, it is eventually converted into adrenaline. Adrenaline has an 
important role as sympathetic effector in the humoral pathway of the immune 
response. The two main enzymes involved in noradrenaline synthesis, TH and DBH, 
are useful markers to label sympathetic fibres. 
The splenic nerve is the only widely accepted innervation of the spleen and has 
been shown to contain almost exclusively postganglionic sympathetic axons in 
several species (De Potter, Kurzawa, Miserez, & Coen, 1995; Felten, Ackerman, 
Wiegand, & Felten, 1987; Fried et al., 1986; Kinney, Cohen, & Felten, 1994; Saito, 
1990). Noradrenergic terminals of the splenic nerve emerge from the celiac/superior 
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mesenteric plexus ganglion (Rosas-Ballina et al., 2008) and penetrate within the 
spleen associated with the vasculature (Bellinger, Felten, Lorton, & Felten, 1989). 
Similarly, sympathetic fibres enter the BM in association with blood vessels. Arteries 
penetrate the BM, where they branch within the central cavity. Some radial arteries 
connect with the venous sinuses broadly distributed in the marrow through smaller 
arterioles (Travlos, 2006). There are also some radial arteries which connect with 
specific arterioles located in the endosteum: the TZ vessels (Kusumbe et al., 2014), 
which connect arteriolar with sinusoidal vessels. Some periosteal arteries irrigating 
the periosteum can eventually cross through the bone to also supply the TZ vessels. 
Immunostainings against the TH enzyme reveal large noradrenergic fibres around 
arteries and smaller isolated varicosities scattered throughout the BM (Mach et al., 
2002; Tabarowski, Gibson-Berry, & Felten, 1996). The close association of 
endothelial cells, nerve terminals and BMSCs, tightly jointed through gap junctions, 
has given rise to the concept of the “neuroreticular complex” in the BM functioning 
as a syncytium-like unit (K. Yamazaki & Allen, 1990). 
Some sympathetic terminals can also release neuropeptide Y (NPY) in addition to 
noradrenaline; however, the role of NPY in haematopoietic organs is not clear yet. 
Chemical sympathectomy to deplete NPY+ fibres have failed to significantly 
decrease NPY content in the spleen, suggesting a non-neuronal splenic source of 
NPY (Ericsson et al., 1987; Romano, Felten, Felten, & Olschowka, 1991). 
Some studies have described the presence of residual NPY+ fibres in the BM (Mach 
et al., 2002; Tabarowski et al., 1996; K. Yamazaki & Allen, 1990). However, those 
fibres have not been fully characterized and, more importantly, their functional 
relevance in the haematopoietic context is very controversial. Some studies have 
suggested that NPY signalling modulates osteoblastic function (Lee et al., 2015; 
Lundberg et al., 2007; Teixeira et al., 2009), helps to restore BM dysfunction after 
chemotherapy-induced neural damage (M. H. Park et al., 2015) and induces HSPC 
mobilisation (M. H. Park et al., 2016). 
In summary, sympathetic fibres regulate different HSC functions via direct and 
indirect mechanisms involving primarily noradrenaline. 
 
 Introduction 
 
 
15 
 
1.3.3 First functional evidences of adrenergic neural regulation 
of haematopoiesis 
Although multiple histochemical studies had illustrated sympathetic BM innervation, 
the functional relevance of these fibres in haematopoiesis remained elusive until the 
1990s. A first link between immune and neural signalling was identified by Maestroni 
et al. showing that circadian release of melatonin enhances immune function 
(Maestroni & Conti, 1990; Maestroni, Conti, & Pierpaoli, 1988). Subsequent studies 
by the same group have demonstrated that leukocyte reconstitution after BM 
transplantation is dependent on dark/light cycles (Maestroni, Conti, & Pedrinis, 
1992). Chemical sympathectomy with 6-hydroxydopamine (6-OHDA) have 
identified the importance of noradrenaline released from local sympathetic terminals 
in the BM to control leukocyte levels in the peripheral blood (Maestroni et al., 1992). 
Likewise,  noradrenaline has been described to exhibit protective effects against the 
chemotherapeutic agent carboplatin (Maestroni, Togni, & Covacci, 1997). 
Adrenergic control of haematopoietic cells has been demonstrated to be mediated 
via cell-autonomous α1-adrenergic receptor signalling in haematopoietic cells. 
Treatment with adrenergic antagonists (α1-adrenergic and β-adrenergic blockers) 
enhances myelopoiesis in BM and spleen, whereas it interferes with lymphopoiesis 
(Maestroni & Conti, 1994a, 1994b; Maestroni et al., 1992). Although most of these 
experiments have been performed in vitro or under myeloablative conditions, the 
same group has also measured catecholamines in the BM of mice over 24 h and 
has suggested that noradrenaline levels follow circadian oscillations. These first 
evidences by Maestroni et al. lay the basis of all subsequent studies investigating 
the neural regulation of haematopoiesis. 
1.3.4 Neural regulation of HSPC trafficking 
Haematopoietic cells, including HSPC, are in constant circulation between the BM 
and the periphery. This haematopoietic trafficking does not only help to equally 
distribute haematopoietic cells among peripheral organs, but it also helps to 
regenerate the HSPC pool contributing to the maintenance of haematopoiesis 
throughout life (Abkowitz, Robinson, Kale, Long, & Chen, 2003; Smith, Weissman, 
& Heimfeld, 1991). Importantly, some studies at the beginning of this century have 
reported that this “normal traffic” can be altered using certain cytokines and factors 
(T. Ahmed, Wuest, & Ciavarella, 1992). This knowledge has been used to “artificially 
Introduction
 
 
16 
 
move” HSPCs into the bloodstream (a process known as mobilisation, in contrast of 
the physiological HSPC egress) and facilitate HSPC collection by apheresis (J. 
Chen et al., 2006). 
Among several mobilising agents granulocyte-colony stimulating factor (G-CSF) has 
been studied for many years and is now broadly used to mobilise HSPCs for 
transplantation purposes (Molineux, Pojda, Hampson, Lord, & Dexter, 1990). 
However, subsequent experiments using chimeras have demonstrated that G-CSF 
does not act directly on HSPCs, but targets stromal components of the BM (Liu, 
Poursine-Laurent, & Link, 2000). Initially, G-CSF has been proposed to increase the 
levels of proteases such as matrix metalloproteinase-9 (MMP-9), cathepsin G, and 
other serine proteases in the BM. These proteases contribute to degrade key 
chemoattractant molecules involved in HSC maintenance like Cxcl12 and its 
receptor Cxcr4 (Kollet et al., 2006; Levesque, Hendy, Takamatsu, Simmons, & 
Bendall, 2003). However, inhibition of protease activity is not sufficient to abrogate 
G-CSF-induced Cxcl12 reduction and subsequent HSPC mobilisation (Levesque et 
al., 2004), suggesting that other stromal elements are required to mediated the G-
CSF-induced drop of Cxcl12. According to this, it has been shown that a population 
of trophic endosteal macrophages named “osteomacs” are also depleted upon G-
CSF administration. Osteomacs depletion is associated with loss of osteoblasts, 
decreased HSC chemoattractant factors in endosteal niches and HSC mobilisation 
(Winkler et al., 2010). 
Some stromal components targeted by G-CSF have their origin in the nervous 
system. Galactocerebrosides are glycolipids present in myelin sheaths of Schwann 
cells in myelinating fibres of the peripheral nervous system. The enzyme UDP-
galactose;ceramide galactosyl-transferase (Ctg) is responsible for the transfer of 
UDP-galactose to ceramide forming galactosylceramide, which is the main 
galactocerebroside of myelin. G-CSF-induced mobilisation is impaired in Ctg-/- mice 
despite normal protease activity. β2-adrenergic signalling has been identified to 
participate in G-CSF-mediated HSPC mobilisation by inducing osteoblast 
suppression and decreasing osteoblastic Cxcl12 level (Katayama et al., 2006). This 
work expands the previously described adrenergic regulation of osteoblasts during 
bone remodelling (Fu, Patel, Bradley, Wagner, & Karsenty, 2005) and provides 
more evidences supporting a relevant function for sympathetic fibres in modulating 
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HSPC chemoattraction in endosteal niches. β2-adrenergic signalling also directly 
targets human CD34+ cells to stimulate human HSPC proliferation, migration and 
engraftment. Thus, β2-adrenergic signalling in HSPCs cooperates with stromal cell-
mediated β2-adrenergic mechanisms during G-CSF-induced mobilisation (Spiegel 
et al., 2007).  
Circadian oscillations in DNA synthesis rate and progenitor activity (measured in 
vitro as colony-forming units in culture) have been reported in murine and human 
BM (Aardal & Laerum, 1983; Smaaland, Sothern, Laerum, & Abrahamsen, 2002). 
Evidence for the direct involvement β-adrenergic signalling in these circadian 
fluctuations (Byron, 1972) have been proposed, but the underlying mechanisms 
have remained unexplored. Likewise, catecholamine levels in the blood undergo 
circadian fluctuations, suggesting that sympathetic control of haematopoietic cells 
might follow circadian rhythms (Sauerbier & von Mayersbach, 1977). Subsequently, 
levels of sympathetic metabolites (noradrenaline and dopamine) have been shown 
to follow daily fluctuations in the murine BM with maximum values during the night, 
suggesting a circadian regulation of haematopoiesis (Maestroni et al., 1998). 
Central circadian rhythms generated by the suprachiasmatic nucleus have also 
been described to be transmitted to other peripheral organs, such as the liver, via 
the SNS (Terazono et al., 2003). 
Along these lines, it has been shown that HSC egress from the BM to the 
bloodstream follows circadian oscillations dependent on sympathetic signalling 
(Mendez-Ferrer, Lucas, Battista, & Frenette, 2008). Light signals received in the 
suprachiasmatic nuclei at central level are processed and translated into HSC 
egress at peripheral level. Postganglionic sympathetic terminals innervate the BM 
periphery to release noradrenaline and transmit the adrenergic signal to stromal 
cells expressing β3-adrenergic receptor. This leads to the degradation of Sp1 
nuclear transcription factor and Cxcl12 suppression in BMSCs. Circulating HSPCs 
fluctuate in antiphase with Cxcl12 expression and both oscillations are dramatically 
altered when light periods and/or sympathetic signalling are disrupted (Mendez-
Ferrer et al., 2008). 
These circadian oscillations are also present in HSPC human trafficking but inverted 
in time. While the highest HSC accumulation in circulation occurs 5 hours after the 
light stimulus in the murine system, the peak of HSC egress in humans is observed 
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in absence of light during the evening (Lucas, Battista, Shi, Isola, & Frenette, 2008). 
Other species promote HSC release into the bloodstream during their resting period 
independent of light/dark phases. This highlights the importance of molecular clocks 
such as Bmal1 to precisely synchronize circadian oscillations and sustain them in 
the absence of light. The fact that circulating HSC peak coincides with the resting 
phase in both species has been interpreted as a cyclical way to regenerate the BM 
microenvironment and other haematopoietic tissues in a coordinated manner 
(Abkowitz et al., 2003; Smith et al., 1991). Moreover, regeneration of other 
peripheral organs during the resting phase might correlate with higher demands of 
haematopoietic cells (Massberg et al., 2007). 
1.3.5 Neural regulation of haematopoietic ontogeny 
During late stages of murine embryonic development, nerve fibres colonize limb 
buds along with blood vessels in the developmental BM cavity (Calvo & Haas, 1969; 
Miller & McCuskey, 1973). Stainings for pan-neuronal markers like PGP 9.5 and 
GAP-43 have shown the presence of nerve fibres in the perichondrium and 
periosteum of rodent limb buds around birth. Both cholinergic and adrenergic fibres 
have been found in periosteal regions and inside the marrow space during postnatal 
stages (Gajda, Adriaensen, & Cichocki, 2000; Gajda et al., 2010). 
Adult HSCs originate in the aorta gonad mesonephros (AGM) region of the embryo 
at early stages of embryonic development (around embryonic day 10 (E10)). 
Sympathetic signals have been described to contribute to HSC emergence in the 
AGM region (Fitch et al., 2012). After leaving the AGM, HSCs colonize the foetal 
liver (FL) in which they expand to finally engraft the BM at E15 (Dzierzak & Speck, 
2008). HSC migration to the BM initiates at pre-natal stages but extends until two 
weeks after birth (Wolber et al., 2002). During this period, HSCs switch from their 
proliferative FL state to a quiescent phenotype found in the adult BM. Stromal 
components including nerve fibres and Schwann cells, which are still undergoing 
maturation during these postnatal stages, might contribute to the regulation of HSC 
colonisation and quiescence in the developing BM. For instance, a neural crest-
derived BMSC population has been proposed to be important for HSC niche-
formation in the developing BM. These neural crest-derived BMSCs give rise to (or 
even contain) Schwann cell precursors. In contrast to mesoderm-derived BMSCs 
controlling foetal skeletogenesis, quiescent neural crest-derived BMSCs secret 
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higher levels of Cxcl12 and contribute to HSC attraction and BM niche maturation 
(Isern et al., 2014). Thus, the neural crest, as a source of peripheral neurons, 
Schwann cells and BMSCs, might contribute to the regulation of HSC 
microenvironments in the BM. 
During postnatal development, some sympathetic neurons innervating the sternum 
have been reported to switch their neurotransmitter properties upon receiving 
signals from the outer bone surface (“periosteum”). Transplantation of periosteum 
tissue onto skin innervated by sympathetic fibres resulted in neurotransmitter switch 
in some fibres from noradrenergic to cholinergic fate. Interestingly, these 
sympathetic cholinergic fibres are generated mainly during the first two postnatal 
weeks around the time of HSC BM colonisation and niche maturation (Asmus, 
Parsons, & Landis, 2000; Asmus, Tian, & Landis, 2001). Whether these sympathetic 
cholinergic fibres have a role in HSC migration or adult haematopoiesis is still 
unexplored. 
Neurotrophic factors are essential to support growth, survival and differentiation of 
nerve fibres (Henderson, 1996). Three different families of neurotrophic factors 
including neutrophins, the ciliary neurotrophic factor (Cntf) family and the glial cell 
line-derived neurotrophic factor (GDNF) family have been described. The GDNF 
family, which is composed of the ligands GDNF, Nrtn (neurturin), Artn (artemin) and 
Pspn (persephin), has been implicated in the control of immune functions (Vega, 
Garcia-Suarez, Hannestad, Perez-Perez, & Germana, 2003). Although each of 
these specific neurotrophic ligands binds preferentially to a specific co-receptor in 
the Gfrα1-4 family, it is possible some low-affinity bindings to other co-receptors 
because their structural homology. Gfra co-receptors are associated with the 
tyrosine kinase RET-receptor that mediates downstream signalling (Baloh, 
Enomoto, Johnson, & Milbrandt, 2000). GDNF/Gfrα1 is especially important for 
dopaminergic neurons survival (Airaksinen & Saarma, 2002). Additionally, RET-
receptor is expressed in developmental HSCs and neurotrophic factor/RET 
signalling has been shown to promote HSC survival and proliferation (Fonseca-
Pereira et al., 2014). This study pointed neurotrophic factors as novel components 
of BM microenvironments and suggested that Gfra/RET signalling is another 
potential pathway by which ANS might regulate haematopoiesis in the BM. 
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1.3.6 Sympathetic regulation of HSC cell cycle status: 
quiescence vs proliferation 
SNS is not only involved in the dynamic processes that allow HSC migration 
between haematopoietic organs, but also controls HSPC proliferation through cell-
autonomous effects mediated by β2-adrenergic receptor signalling (Spiegel et al., 
2007). Nestin+ BMSC, which mediate sympathetic fibre-controlled HSC traffic to 
extramedullary sites via Cxcl12, also express other HSC maintenance genes such 
as Scf or Ang1 (Mendez-Ferrer, Michurina, et al., 2010). Non-myelinating Schwann 
cells, which unsheathe sympathetic nerve fibres, contribute to maintain HSC 
quiescence. Schwann cells release Tgf-β in the BM, which binds to Tgf-β type II 
receptor in HSCs and triggers Smad-mediated quiescence. Sympathetic 
denervation resulting in Schwann cell loss leads to a quick reduction of BM HSCs 
(S. Yamazaki et al., 2011). Therefore, peripheral sympathetic neurons and their 
associated Schwann cells appear to have the capacity to directly and indirectly 
regulate HSC proliferation. 
1.3.6 Parasympathetic innervation of haematopoietic organs 
The presence of parasympathetic innervation in haematopoietic organs has 
remained debated for many years. Retrograde tracing experiments performed in 
rodents and cat has suggested the existence of parasympathetic innervation in the 
spleen (Branen et al., 2004; Buijs, van der Vliet, Garidou, Huitinga, & Escobar, 2008; 
X. H. Chen, Itoh, Sun, Miki, & Takeuchi, 1996). Still, most groups working in this 
field doubt the existence of parasympathetic fibres in the spleen and argue for 
interspecies differences. (Bellinger, Lorton, Hamill, Felten, & Felten, 1993; Cano, 
Sved, Rinaman, Rabin, & Card, 2001; Nance & Sanders, 2007). Recently, 
cholinergic fibres with spinal origin have been detected around arterioles in the white 
pulp of the spleen (Gautron et al., 2013). 
However, there is strong evidence for a cholinergic anti-inflammatory reflex in the 
spleen initiated by the PNS (Huston et al., 2006; Rosas-Ballina et al., 2008; Vida, 
Pena, Deitch, & Ulloa, 2011). This pathway involves an indirect regulation by the 
parasympathetic vagus nerve via the celiac plexus, from where the splenic nerve 
emerges to innervate the spleen. The splenic nerve is catecholaminergic and 
innervates an Ach-producing T cell population via β2-adrenergic signalling in the 
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spleen. Upon stimulation by noradrenaline, these T cells produce Ach to activate 
α7-nicotinic receptors on macrophages resulting in the downregulation of pro-
inflammatory cytokines and dampening of the immune response (Rosas-Ballina et 
al., 2011). Whereas this study describes the importance of cholinergic immune 
control in the spleen despite the absence of direct PNS innervation, other groups 
have reported the existence of splenic PNS fibres with anti-inflammatory function 
(Kooijman et al., 2015). These studies have fostered the significant controversy in 
the field regarding parasympathetic innervation of the murine spleen (Anderson, 
McKinley, Martelli, & McAllen, 2015). 
Besides the controversial parasympathetic innervation of the spleen, 
neuroanatomical evidence of a parasympathetic supply to the BM is scarce (Nance 
& Sanders, 2007). Immunohistochemistry studies of the enzyme choline 
acetyltransferase (ChAT) has been used to label parasympathetic fibres in the BM 
of the rat (Artico et al., 2002). Another study has used the cholinergic marker 
vesicular acetylcholine transporter (VAChT) and retrograde tracing with 
pseudorabies virus to suggest the presence of PNS terminals transmitting bone-
anabolic signals from the brain. The sacral intermediolateral cell column and the 
central autonomic nucleus has been identified as origin of PNS fibres in the bone 
(Bajayo et al., 2012). However, the possibility of an indirect vagal input (as it occurs 
in the spleen) through sympathetic postganglionic terminals innervating the BM 
cannot be excluded. Hence, another group has reported bone-anabolic PNS signals 
regulating bone mass indirectly through the inhibition of central sympathetic tone 
(Shi et al., 2010). Sympathetic fibres that regulate bone remodelling also innervate 
the BM, suggesting the possibility of haematopoietic regulation by the PNS at the 
central level. 
Recently, central cholinergic signals have been shown to control G-CSF-mediated 
HSPC mobilisation in the BM through a glucocorticoid signalling relay. Cholinergic 
signalling mediated by muscarinic receptor type-1 (Chrm1) is transmitted from the 
hypothalamus to the hypothalamic-pituitary-adrenal axis, where it promotes 
glucocorticoid hormones release. Physiological levels of corticosterone lead to HSC 
mobilisation via the glucocorticoid receptor Nr3c1-dependent signalling and 
reorganization of actin cytoskeleton in HSPCs (Pierce et al., 2017).  
Introduction
 
 
22 
 
Vasoactive intestinal peptide (VIP) is a neurotransmitter mostly associated with 
parasympathetic signalling which has been identified in nerve fibres supplying the 
spleen and the BM. Only residual VIP-immunoreactive fibres have been found along 
the splenic vasculature, where they might modulate lymphocyte function during the 
inflammatory response (Chevendra & Weaver, 1992). VIP+ fibres have also been 
found in the BM and the periosteum in rats with particular abundance in the growth 
plate and intervertebral discs (M. Ahmed, Bjurholm, Kreicbergs, & Schultzberg, 
1993). The VIP receptor (VPAC1) has been detected in human megakaryocytes (S. 
K. Park, Olson, Ercal, Summers, & O'Dorisio, 1996), in which autocrine VIP-
signalling has been suggested to inhibit megakaryocyte proliferation and 
differentiation (Nam, Case, Hostager, & O'Dorisio, 2009). However, VIP/VPAC1-
signalling exhibits opposite effects on proliferation and clonogenic capacity of 
HSPCs isolated from human BM or human umbilical cord blood (Kawakami et al., 
2004; Rameshwar et al., 2002). It is also important to note that VIP is not exclusively 
present in parasympathetic terminals, but a net of sympathetic VIP-immunoreactive 
nerve fibres has been described to innervate the periosteum and bone in several 
species (Hohmann, Elde, Rysavy, Einzig, & Gebhard, 1986). In contrast, VIP+ fibres 
in the spleen are not affected by sympathectomy (Bellinger et al., 1997), suggesting 
that these fibres are parasympathetic. 
In conclusion, the evidence for cholinergic fibres in haematopoietic organs remains 
very limited and controversial, highlighting the urgent need to study the possible 
cholinergic regulation of haematopoiesis to improve the current understanding of 
neural control mechanisms in the HSC niche. 
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2 Aims 
A considerable number of studies in the last decades has revealed the importance 
of the nervous system as a master regulator of haematopoiesis. The autonomic 
nervous system relays signals from the CNS to haematopoietic organs. Although 
several studies have suggested that the innervation of BM and spleen might derive 
from both branches of the autonomic nervous system (SNS and PNS), only the 
sympathetic regulation of haematopoiesis has been validated at the peripheral level 
by functional studies. Whereas the SNS is an established regulator of HSC 
maintenance and trafficking, parasympathetic innervation has not been studied in 
detail in haematopoietic organs and the evidence of cholinergic regulation at this 
level is limited to the orchestration of the cholinergic anti-inflammatory reflex. 
Despite significant advances in the field of BM niche regulation and the description 
of numerous “niche elements”, an integrated vision of how these different 
components ultimately regulate HSC function is lacking. Different BM niches have 
been described in spatially distinct locations in the BM. While endosteal niches 
mainly contribute to the maintenance of dormant/quiescence HSCs, perisinusoidal 
niches in the central part of the marrow have been demonstrated to harbour the vast 
majority of active HSCs. However, how these spatially separated niches 
physiologically and coordinately regulate haematopoiesis is still elusive. It remains 
to be shown whether these niches harbour different HSC populations or if they work 
as a dynamic system in which HSCs are exchangeable between niches and show 
different behaviours depending on the niche they occupy over time. 
In this study, we propose that the other branch of the autonomic nervous system, 
the PNS, might also regulate the BM stem cell niche. To address this question, it is 
important to dissect whether the PNS directly contributes to haematopoiesis through 
cholinergic signalling, or whether it indirectly modulates HSC function by 
antagonizing sympathetic activity, as it occurs in other peripheral organs. Thus, the 
aims of this study are: 
1) Investigation of the pathways by which the PNS might transmit 
cholinergic signals to the BM. 
2) Characterization of the roles of cholinergic signalling in regulating HSC 
function in different BM stem cell niches in a spatiotemporal context. 
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“Siempre hay que buscar la perfección. 
Para mí significa: de una tela a otra, ir siempre más lejos, más lejos.” 
Pablo Picasso 
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3 Materials and Methods 
 
3.1  Materials 
 
3.1.1  Mouse strains 
Table 1 Mouse strains 
 
  
MOUSE STRAIN SOURCE IDENTIFIER 
Mouse: Gfra2-/- Rossi et al., 1999 N/A 
Mouse: Nes-gfp 
G.E.Enikolopov ; Mignone 
et al., 2004 
N/A 
Mouse: Adrb2tm1Bkk/J 
G. Karsenty ; Chruscinkski 
et al., 1999 
N/A 
Mouse: FVB/N-Adrb3tm1Lowl The Jackson Laboratory JAX: 006402 
Mouse: B6.129S7-Chrna7tm1Bay/J The Jackson Laboratory JAX: 003232 
Mouse: Th-IRES-Cre 
T. Ebendal ; Lindeberg et 
al., 2004 
N/A 
Mouse: Dhh-IRES-Cre gift N/A 
Mouse: ChAT-IRES-Cre gift N/A 
Mouse: B6.Cg-Gt(ROSA)26Sortm14(CAG-
tdTomato)Hze/J 
The Jackson Laboratory JAX: 007914 
Mouse: B6.SJL-Ptprca Pepcb/BoyJ The Jackson Laboratory JAX: 002014 
Mouse: C57BL/6J The Jackson Laboratory JAX: 000664 
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3.1.2  Cell lines 
Table 2 Cell lines 
CELL LINE SOURCE IDENTIFIER 
MS-5 murine stromal cell line ATCC N/A 
ST-2 murine stromal cell line ATCC N/A 
MC3T3-E1 murine osteoblastic cell line ATCC CRL-2593 
MLO-Y4 osteocyte-like cell line ATCC N/A 
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3.1.3  Antibodies 
Table 3 Antibodies list 
ANTIBODY SOURCE IDENTIFIER 
PE-Cy™7 Mouse Anti-Mouse 
CD45.1  Clone  A20 
BD Biosciences Cat#560578 
APC-Cy™7 Mouse Anti-Mouse 
CD45.2  Clone  104 
BD Biosciences Cat#560694 
FITC Rat Anti-Mouse 
CD45R/B220  Clone  RA3-6B2 
BD Biosciences Cat#553088 
APC Rat Anti-Mouse CD11b Clone  M1/70 BD Biosciences Cat#553312 
PerCP-Cy™5.5 Hamster Anti-Mouse 
CD3e  Clone  145-2C11 
BD Biosciences Cat#561108 
PE Rat Anti-Mouse Ly-6G Clone  1A8 BD Biosciences Cat#561104 
PE Rat Anti-Mouse CD90.2  Clone  53-2.1 BD Biosciences Cat#553005 
PE Rat Anti-Mouse Ly-6A/E  Clone  E13-161.7 BD Biosciences Cat#553336 
FITC Rat anti-Mouse CD34  Clone  RAM34 BD Biosciences Cat#560238 
APC Rat Anti-Mouse CD135  Clone  A2F10.1 BD Biosciences Cat#560718 
Biotin Mouse Lineage Panel (CD11b, Gr-1, 
Ter119, B220, CD3e) 
BD Biosciences Cat#559971 
Anti-Mouse CD117 (c-Kit) PE-Cyanine7 eBioscience Cat#25-1171-82 
APC anti-mouse CD150 (SLAM) Antibody 
Clone TC15-12F12.2 
BioLegend Cat#115910 
PerCP/Cy5.5 anti-mouse CD41 antibody Clone 
MWReg30 
BioLegend Cat#133918 
Streptavidin APC-Cy™7 BD Biosciences Cat#554063 
Biotin Rat Anti-Mouse CD45  Clone  30-F11 BD Biosciences Cat#553077 
Biotin Rat Anti-Mouse CD31  Clone  MEC 13.3 BD Biosciences Cat#553371 
Biotin Rat Anti-Mouse TER-119/Erythroid 
Cells  Clone TER-119 
BD Biosciences Cat#553672 
Purified monoclonal anti-mouse P-selectin 
Clone RB40.34 
gift N/A 
Purified monoclonal anti-mouse α4 integrin 
Clone PS/2 
gift N/A 
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Rat anti-mouse E-selectin Clone 9A9 B. Wolitzky N/A 
Human/Mouse CXCL12/SDF-1 Antibody R&D Systems Cat# MAB350 
Human/Mouse CXCL12/SDF-1 
Biotinylated Antibody 
R&D Systems Cat# BAF310 
Rabbit polyclonal tyrosine hydroxylase 
antibody 
Millipore Cat# AB152 
Chicken polyclonal Green Fluorescent (GFP) 
antibody 
Aves Cat# GFP-1020 
Living Colors® Full-Length GFP Polyclonal 
Antibody 
Clontech Cat# 632592 
Rabbit Anti-Choline Acetyltransferase antibody Abcam Cat# Ab178850 
Rabbit Anti-Choline Acetyltransferase antibody 
Phoenix 
Pharmaceuticals 
Cat# H-V006 
APC anti-mouse CD48 antibody Clone HM48-
1 
BioLegend Cat# 103411 
BV421 anti-mouse Sca1 antibody Clone D7 BioLegend Cat# 108128 
PE-Cy7 anti-mouse CD150 antibody Clone 
TC15-F12.2 
BioLegend Cat# 115914 
APC-Cy7 anti-mouse ckit antibody Clone 2B8 BioLegend Cat# 105856 
BV510 Streptavidin BioLegend Cat# 405233 
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3.1.4  Biochemical reagents 
Table 4 Biochemical reagents list 
BIOCHEMICAL REAGENT SOURCE IDENTIFIER 
Collagenase from Clostridium histolyticum Sigma-Aldrich Cat# C2674 
BD IMag™ Streptavidin Particles Plus  BD Biosciences Cat# 557812 
Lympholyte®-M Cell Separation Media Cedarlane Cat# CL5031 
Hydrocortisone 
StemCell 
Technologies 
Cat# 07904 
MyeloCult™ M5300 
StemCell 
Technologies 
Cat# 05300 
G-CSF (Filgrastim) gift N/A 
5-fluoruracil Sigma-Aldrich Cat# F6627 
6-Hydroxydopamine hydrochloride Sigma-Aldrich Cat# H4381  
Detoxi-GelTM Endotoxin Removing 
Columns 
Pierce 
Biotechnology 
Inc 
N/A 
Tetramethylrhodamine isothiocyanate–
Dextran 
Sigma-Aldrich Cat# T1037 
VECTASHIELD HardSet Antifade 
Mounting Medium 
Vector 
Laboratories 
Cat# H-1400 
Alexa Fluor® 488 Phalloidin 
Molecular 
ProbesTM 
Cat# A12379 
Peroxidase-Conjugated Streptavidin DAKO Cat# P 0397 
TMB/E Single Reagent, Blue color, 
Horseradish Peroxidase Substrate  
Millipore Cat# ES001 
Recombinant Human/Rhesus 
Macaque/Feline CXCL12/SDF-1 alpha 
R&D Systems Cat# 350-NS 
Penicillin-Streptomycin Invitrogen Cat# 15140122 
L-ascorbic acid 2-phosphate Sigma-Aldrich Cat# A8960 
Giemsa Stain Sigma-Aldrich Cat# 32884 
SIGMAFAST BCIP/NBT Sigma-Aldrich Cat# B5655 
Proteinase K Sigma-Aldrich 
Cat# 
3115801001 
REDTaq Ready Mix PCR Reaction Mix Sigma-Aldrich Cat# R2523 
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3.1.5  Commercial assays kits 
Table 5 Commercial assays kits list 
COMMERCIAL ASSAYS KIT SOURCE IDENTIFIER 
VECTASTAIN Elite ABC HRP Kit Vector Laboratories Cat# PK-6100 
TSA Cyanine 3 Tyramide Reagent Pack PerkinElmer 
Cat# 
SAT704A001EA 
Bi-CAT (Epinephrine & Norepinephrine) 
ELISA 
ALPCO 
Cat# 17-
BCTHU-EO2.1 
Acetylcholinesterase Activity Assay Kit Sigma-Aldrich Cat# MAK119 
MouseTRAP (TRAcP 5b) ELISA Immunodiagnosticsystems Cat# SB-TR103 
MicroVue DPD ELISA Quidel N/A 
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3.1.6  Sequence-based reagents 
Table 6 Sequence-based reagents list 
SEQUENCE-BASED REAGENT SOURCE IDENTIFIER 
Primers for genotyping and quantitative real-
time RT-PCR (Table 10 and 11). 
  
RNeasy Mini Kit QIAGEN Cat# 74104 
Dynabeads® mRNA DIRECT™ Micro 
Purification Kit 
AmbionTM Cat# 61021 
Reverse Transcription System Promega Cat# A3500 
SuperScript® II Reverse Transcriptase ThermoFisher Cat# 18064071 
KAPA HiFi Hotstart ReadyMix KAPA Biosystems Cat# KK2601 
Agencourt AMPure XP beads Beckman Coulter Cat# A63881 
Quant-iT™ PicoGreen® dsDNA Assay Kit ThermoFisher Cat# P7589 
KAPA qPCR quantification kit KAPA Biosystems Cat# KK4824 
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3.1.7  Software 
Table 8  Software list 
SOFTWARE SOURCE IDENTIFIER 
FACSDiva Software  BD Biosciences N/A 
Poisson statistics. L-CalcTM software.   
StemCell 
Technologies 
N/A 
ImageJ Software. Java N/A 
GraphPad Prism  GraphPad N/A 
Microsoft Excel Microsoft Office N/A 
GSNAP  N/A 
Version 2015-09-
29 
Htweq-count N/A 
HTSeq version 
0.5.3p3 
Nucline software 
Mediso, Budapest, 
Hungary. 
N/A 
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3.2  Methods 
 
3.2.1 Mouse strains 
The following mouse strains were used in this study (see Table 1 for more details): 
 Gfra2-/- (Rossi et al., 1999). This mouse model lacks the receptor for 
neurturin, a member of the glial cell-derived family of neurotrophic factors, 
and exhibits deficits in the enteric and parasympathetic nervous system. 
 Nes-gfp (Mignone et al., 2004) (gift from G.E. Enikolopov). Mouse model 
expressing GFP under the promoter of the nestin gene. This strain was bred 
with Gfra2-/- mice to generate Nes-gfp; Gfra2-/- mice. 
 Adrb2tm1Bkk/J (Chruscinski et al., 1999). This mouse strain lacks functional 
adrenergic receptor β2. This strain was bred with Gfra2-/- model to get double 
Adrb2-/-; Gfra2-/- mice. 
 Adrb3tm1Lowl. This mouse strain lacks adrenergic receptor β3. This strain 
was bred with Gfra2-/- model to get double Adrb3-/-; Gfra2-/- mice. 
 B6.129S7 Chrna7tm1Bay/J. This mouse model lacks the nicotinic cholinergic 
receptor α7. 
 Th-IRES-Cre (Lindeberg et al., 2004) (gift from T. Ebendal). This mouse 
model expresses Cre recombinase under the tyrosine hydroxylase promoter 
and labels sympathetic fibres. 
 Dhh-IRES-Cre (gift of D.N. Meijer). This mouse model expresses Cre 
recombinase under control of the mouse desert hedgehog (Dhh) 
promoter/regulatory regions. 
 ChAT-IRES-Cre. This strain expresses Cre recombinase in cholinergic 
neurons, without disrupting endogenous ChAT expression. 
 B6.Cg-Gt(ROSA)26Sortm14(CAGtdTomato) Hze/J. This reporter strain 
harbours a loxP-flanked STOP cassette preventing transcription of a CAG 
promoter-driven tdTomato red fluorescent protein from the Gt(ROSA)26Sor 
locus. This strain was bred with the different strains expressing Cre 
recombinase to label Cre-expressing cells. 
 Congenic CD45.1 and CD45.2 C57BL/6J mice (Jackson Laboratories).  
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Mice were age- and sex-matched and housed in specific pathogen free facilities. All 
experiments using mice followed protocols approved by the Animal Welfare Ethical 
Committees and were compliant with EU recommendations. 
3.2.2 Cell culture methods 
 
3.2.2.1 Cell lines 
Cell lines were purchased from ATCC (see Table 2 for more details).  
MS-5 murine stromal cells were grown in a monolayer using α-MEM supplemented 
with 10% foetal bovine serum (FBS), 2mM l-glutamine and 2mM sodium pyruvate 
(Invitrogen).  
The stromal cell line ST-2 was grown in RPMI1640 medium containing 10% FBS. 
MC3T3-E1 cells are osteoblastic precursors derived from mouse skull. They were 
grown in α-MEM medium supplemented with 10% FBS.  
The osteocyte-like cell line MLO-Y4 was seeded in collagen I pre-coated-6 well 
dishes and grown with α-MEM medium supplemented with 5% FBS and 5% iron-
supplemented calf serum (Invitrogen). 
3.2.2.2 Cell maintenance 
All cultures were maintained with 1% penicillin–streptomycin (P/S) (Invitrogen) at 37 
°C in a water-jacketed incubator with 5% CO2. Cells were split 1:5 with 0.05% 
trypsin/EDTA (Invitrogen) every three or four days when cells reached about 80% 
confluence. Routine tests confirmed the absence of mycoplasma contamination in 
the cultures. 
3.2.2.3 Colony-forming-unit culture (CFU-C) assay 
For measurement of HSPCs in vitro CFU-C assay was performed from blood and 
BM samples. 500µl of diluted blood samples were layered carefully over 2ml of 
Lympholite-M (Cedarlane). Tubes were centrifuged at room temperature (RT) for 
25min, 1350 rpm with slow acceleration and without rotor brake. The mononuclear 
white blood cell fraction was collected and mixed with methylcellulose medium 
(recipe). Then 1ml cell suspension was seeded with an 18G syringe into non-
adhesive 35mm culture dishes (Stem Cell Technologies). For BM samples, 104 BM 
nucleated cells were mixed with methylcellulose-based media and seeded into 
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35mm dishes as previously described (Frenette, Subbarao, Mazo, von Andrian, & 
Wagner, 1998). Colonies were scored after 7 days of culture. 
For the fibroblastic colony-forming unit (CFU-F) assay, 106 BM nucleated cells were 
seeded into wells of 6-well plates and cultured at 37°C, 5% CO2 in a water-jacketed 
incubator with -MEM supplemented with 15% FBS, 1% (P/S) and 1mM l-ascorbic 
acid 2-phosphate (Sigma). After 10-12 days in culture, adherent cells were fixed 
with 100% methanol and stained 10min with Giemsa Stain (Sigma) at 37ºC to reveal 
fibroblastic colonies. Giemsa Stain is diluted 1:10 in phosphate buffer pH 6.8.  
For the colony-forming unit-osteoblast (CFU-OB) assay, cells were allowed to grow 
in the same medium for 28 days, with half-medium changes twice a week. After this 
period, adherent cells were fixed with cold 4% paraformaldehyde (PFA) in PBS and 
alkaline phosphatase staining (Sigma Fast BCIP/NBT) was performed to reveal 
osteoblastic clusters. Alkaline phosphatase substrate was diluted in 10ml of dH2O 
to prepare fresh staining solution. Cells were incubated with alkaline phosphatase 
solution for 10min protected from light. 
For all the CFU-C assays, colonies with more than 50 cells were scored as positive. 
3.2.2.4 BM primary cultures 
BM myeloid cultures were obtained by seeding 3 x 106 BM cells into wells of 6-well 
plates with M5300 medium supplemented with 0.1μM hydrocortisone (StemCell 
Technologies), 1% P/S and 1% fungizone. Cells were maintained at 33°C and 5% 
CO2 in a water-jacketed incubator. Half medium changes were performed weekly 
and cells were pharmacologically treated after two weeks in culture. 
3.2.3 Biochemical methods 
 
3.2.3.1 Blood, BM and spleen cell extraction 
For BM haematopoietic cell isolation, bones were crushed in a mortar and filtered 
through a 40-μm strainer to obtain single cell suspensions. Adult and foetal livers as 
well as spleens were mechanically dispersed on a 40μm strainer. All cell 
suspensions were depleted of red blood cells by lysis in 0.15M NH4Cl for 10min at 
4ºC. Blood samples were directly lysed at RT. 
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To isolate HSPCs from bone-associated and non-associated marrow fractions, long 
bones were flushed gently with a 21G needle to obtain non-endosteal 
haematopoietic cells. The remaining bones were then crushed in a mortar to obtain 
haematopoietic cells of the endosteal compartment (Fig. 5).  
To isolate nestin+ cells, bones were cleaned from surrounding tissue, crushed in a 
mortar with a pestle, and digested with 0.25% collagenase/20% FBS/PBS (C2674, 
Sigma) in a water bath at 37ºC for 30min with agitation. Cells were filtered through 
a 40μm strainer and erythrocytes were lysed as described above. The resulting BM-
enriched cell suspensions were pelleted, washed and resuspended in PBS 
containing 2% FBS for further analyses.  
 
Figure 5. Scheme showing the protocol for enrichment of endosteal and non-
endosteal BM fractions. To separate endosteal and non-endosteal nestin+ cells, 
long bones were gently flushed as described above. The flushed fraction and the 
remaining bone sample were digested with 0.25% collagenase/20% FBS/PBS 
(C2674, Sigma) in a water bath at 37ºC for 30min with agitation. 
3.2.3.2 Flow-cytometry and fluorescence-activated cell sorting (FACS) 
Cells suspensions were incubated with the appropriate dilution (2-5 μg/ml) of 
fluorescent antibody conjugates in 2% FBS/PBS for 20min on ice. After washing 
with 2% FBS/PBS dead cells were excluded by 4',6-diamidino-2-phenylindole 
(DAPI) staining (1:3000). Cells were analysed on LSRFortessa flow cytometer (BD 
Biosciences, Franklin Lakes, NJ) equipped with FACSDiva Software (BD 
Biosciences), or sorted on Aria III cell sorter or BD Influx sorter (BD Bioscience). 
The following antibodies were used to label haematopoietic cells (see Table 3 for 
more details): fluorescent CD45.1 (A20), CD45.2 (104), B220 (RA3-6B2), CD11b 
(M1/70), CD3e (145-2C11), LY-6G (1A8), CD90 (53-2.1), SCA1 (E13-161.7), CD34 
(RAM34), CD135/flt3 (A2F10.1) and biotinylated lineage (LIN) antibodies (CD11b, 
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Gr-1, TER119, B220, CD3e) (BD Biosciences); cKIT (2B8) (eBioscience); CD150 
(TC15-12F12.2), CD41 (MWReg30), CD48 (HM48-1) and SCA1 (D7) (BioLegend). 
Biotinylated antibodies were detected with fluorochrome-conjugated streptavidin 
(BD Biosciences). HSCs were immunophenotypically defined as LIN-CD41-
SCA1+cKIT+CD150+ cells. 
BM stromal cells were defined as CD45-CD31-Ter119- and further purified according 
to Nes-GFP fluorescence (Nestin-gfp).  
3.2.3.3 Cell cycle analysis 
Cell cycle was analysed in sorted HSCs (defined as LIN-CD41- SCA1+cKIT+CD135- 
cells) to study their quiescence/proliferative status. Hoechst 33342 (H42) and 
Pyronin Y (PY) staining to discriminate G0 (H42-PY-), G1 (H42-PY+) and G2/M/S 
(H42+PY+) cell cycle phases was performed as described in previously (Sanchez-
Aguilera et al., 2014). 
Briefly, sorted HSCs were collected in α-MEM medium supplemented with 2% FBS 
and 10mM HEPES. Cells were incubated with H42 (5μg/ml) 35min in α-MEM 
medium supplemented with 2% FBS, 10mM HEPES and 50μM verapamil at 37ºC. 
PY (1μg/ml) was added and the cells were incubated 20min at 37ºC. Finally, cells 
were resuspended in medium containing 50μM verapamil and analysed by flow 
cytometry. 
3.2.3.4 Long-term competitive repopulation assay 
HSC activity was assessed by long-term competitive repopulation assay using the 
congenic CD45.1 and CD45.2 isotypes of haematopoietic cells. Recipient female 
CD45.1 C57BL/6 mice (8 weeks old) were subjected to lethal irradiation (137Cs 
source, 11-12Gy whole body irradiation, split dose, 3h apart). To measure 
circulating HSCs, various blood volumes (75, 150 and 300μl) obtained from 
(CD45.2) 8-week-old male Gfra2-/- mice and control Gfra2+/- littermates were mixed 
with 2 × 105 BM nucleated cells from CD45.1 C57BL/6 mice in 200μl sterile PBS 
and intravenously (i.v) transplanted into the lethally-irradiated CD45.1 C57BL/6 
mice. At various time points after transplantation (4, 8, 12 and 16 weeks), peripheral 
blood nucleated cells were collected from recipients. Cells were stained with 
fluorescent-conjugated antibodies against B220, MAC1 and CD90 antigens, and 
analysed by flow cytometry. The percentage of recipients in which reconstitution 
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failed was plotted against the number of transplanted cells and Poisson statistics (L-
CalcTM software, StemCell Technologies) was applied to calculate the HSC 
concentration within the donor samples. 
To measure BM HSC activity from endosteal and non-endosteal compartments, 106 
BM nucleated cells from flushed BM or the remaining endosteal fraction of Gfra2+/- 
or Gfra2-/- (CD45.2) mice were used as donor cells. These cells were transplanted 
into lethally irradiated CD45.1 mice together with 106 CD45.1 competitor BM 
nucleated cells. Haematopoietic reconstitution was assessed in the peripheral blood 
of recipient mice after 24 weeks by measuring blood CD45.2 chimerism in the 
different mature haematopoietic lineages.  
3.2.3.5 Homing of haematopoietic progenitors 
To study BM HSPC homing in conditioned recipients, Gfra2-/- mice and control 
Gfra2+/- mice were lethally irradiated (137Cs source, 9.5Gy whole body irradiation, 
one dose). After 3h, 5 x 106 nucleated cells from congenic CD45.1 C57BL/6 donor 
mice were i.v. injected in 200μl PBS into each recipient mouse.  
To study BM HSPC homing in unconditioned recipients, we enriched lineage 
negative donor cells by incubating BM nucleated cells obtained from CD45.1 
C57BL/6 or Gfra2-/- mice. Cell suspensions were stained for 20min with biotinylated 
lineage antibodies (BD Biosciences) diluted in 2% FBS/PBS. After washing with 
0.5% BSA/2mM EDTA in PBS, samples were incubated for 30min with streptavidin-
conjugated magnetic beads (BD Bioscience) diluted in 0.5% BSA/2mM EDTA in 
PBS. Then, samples were placed in a magnetic particle concentrator (DynaMag, 
Invitrogen) for 8min to deplete LIN+ cells. 5 x 106 haematopoietic lineage-depleted 
CD45.1 WT or Gfra2-/- nucleated cells were i.v. injected in 200μl PBS into Gfra2-/-  
mice and control CD45.1 WT or Gfra2+/- mice (CD45.2).  
HSPC homing was assessed 16 hours after transplantation. BM and blood were 
harvested and used for CFU-C assay, as described below. 
3.2.3.6 In vivo treatments 
The following drugs were administered to mice according study plans approved by 
the local animal welfare committees for studying physiological responses in vivo 
(see Table 4 for more details): 
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- Granulocyte colony-stimulating factor (G-CSF; Filgrastim). HSPC 
mobilisation was induced with 8 consecutive injections of G-CSF (125μg/kg 
every 12h, sub-cutaneously (s.c.), dissolved in 5% dextrose in PBS). Five 
hours after the last injection mice were bled and CFU-C assay was 
performed. 
- 5-fluoruracil (5-FU). A single dose of 5-FU (150 mg/kg, intra peritoneal (i.p.), 
diluted in PBS) was administered to assess haematopoietic recovery after 
myelosupressive stress. Mice were bled before the 5-FU injection and then 
every 3-4 days for haematological analysis. 
- 6-hydroxydopamine (6-OHDA; Sigma). 6-OHDA is a neurotoxic synthetic 
compound used for chemical sympathetic denervation. Mice were s.c. 
injected with 6-OHDA (100 mg/kg, diluted in 0.2% ascorbic acid in 0.9% 
NaCl) on postnatal days P2, P4, P6, P8 and P9. 
- Homing blocking antibodies. The following antibodies (1mg/kg) were injected 
i.v. for pharmacological blocking of HSPC homing. Rat monoclonal 
antibodies against P-selectin (RB40.34) and mouse α4 integrin (PS/2) were 
purified from hybridoma supernatants and subjected to potential endotoxin 
decontamination with a polymyxin B column (Detoxi-Gel; Pierce 
Biotechnology Inc.). Rat anti–mouse E-selectin Ab (9A9) was a gift from B. 
Wolitzky. Control rat IgG was obtained from Sigma.  
- Nicotinic blocking drugs. For pharmacological nicotinic blockage 
experiments, mice were injected with 2 doses of methylatropine nitrate, 
mecamylamine (3mg/kg, diluted in PBS, i.p.) or vehicle on consecutive days. 
Peripheral blood was harvested five hours after the second dose. 
3.2.4 Imaging & Immunoassays methods 
 
3.2.4.1 Immunostaining 
Immunofluorescence staining of 10µm cryo-sections was performed as previously 
described (Isern et al., 2014). Briefly, frozen tissues were allowed to thaw for 15min 
and slightly rinsed in PBS. Tissue sections were permeabilised with 0.1% Triton X-
100 (Sigma) for 10min at RT and blocked with TNB buffer (0.1M Tris–HCl, pH 7.5, 
0.15M NaCl, 0.5% blocking reagent, Perkin Elmer) for 1h at RT. Primary antibody 
incubations were conducted for 2h at RT. After 3 washing steps with 0.05%Triton-
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X-100/PBS secondary antibody incubations were performed for 1h at RT. Stained 
tissue sections were counterstained for 5min with 5μM DAPI and rinsed with PBS. 
Slides were mounted in Vectashield Hardset mounting medium (Vector Labs) and 
sealed with nail polish. For whole mount staining of long bones and skull, all 
incubation times were extended.  
We used the following primary antibodies (see Table 3 for more details): anti-
tyrosine hydroxylase (1:1000, rabbit polyclonal antibody, Millipore), anti-GFP 
(1:200, chicken polyclonal, Aves), living colors full-length anti-GFP (1:500, rabbit 
polyclonal, Clontech) and anti-VAChT (1:100, rabbit polyclonal antibody, Abcam 
and Phoenix laboratories). Tyrosine hydroxylase staining included an amplification 
step using the Vectastain Elite ABC Kit (Vector Labs) and Cy3-Tyramide 
(PerkinElmer). Osteocyte projections were detected incubating for 48h with 
Alexa488-conjugated phalloidin (Sigma). Confocal images were acquired with a 
laser scanning confocal microscope (Zeiss LSM 700) or with a multiphoton confocal 
microscope (Zeiss LSM 780). At least 3 different sections per sample were blindly 
analysed using ImageJ software. 
3.2.4.2 Intravital microscopy 
Intravital microscopy is a very useful imaging tool that allows the study of 
physiological processes in living animals (Fig. 6). In this case we chose the skull BM 
for in vivo imaging of the vascular integrity. The skull cortical bone layer is sufficiently 
thin to allow for light penetration, avoiding to disrupt the BM microarchitecture. 
Anesthetized Gfra2+/- and Gfra2-/- mice were i.v. injected with 100µg Dextran-TRITC 
(1µg/µl in PBS 70 kDa, Sigma). Then mice were prepared for skull imaging. After 
depilating the skull area, an incision was made in the skin to expose the bone. Mice 
were placed in an animal holder to stabilize their position and maintain the body 
temperature. Imaging was performed through an “imaging window” created with a 
plastic ring fixed with hydrophobic glue and filled with PBS to keep the tissue 
hydrated. Acquisition was performed with a multiphoton confocal microscope (Zeiss 
LSM 780). The BM cavities closer to the parietal bones and distributed parasagitally 
along the sagittal suture were used for vasculature imaging. After imaging process 
mice were euthanized according to animal procedures legislation. 
 Materials and Methods 
 
 
43 
 
 
Figure 6. Illustration of the experimental setup for skull BM intravital 
microscopy. Calvarium structures are shown using near-infrared spectroscopy (A) 
and confocal microscopy (B). C, 3D reconstruction of skull BM vasculature is shown. 
D, Scheme showing mouse position while intravital imaging. 
3.2.4.3 Sample preparation and staining for electron microscopy 
Pre-anesthetised Gfra2+/- and Gfra2-/- mice were transcardially perfused with 2% 
formaldehyde (made from PFA) and 2% vacuum distilled glutaraldehyde, containing 
2ml/l CaCl2, in 0.05M sodium cacodylate buffer at 4 ⁰C and pH 7.4. Bones were 
removed and post-fixed by immersion in fixative solution for 24h at 4ºC. Bones were 
decalcified for one week with several changes of 0.25M EDTA in 20% fixative 
solution in dH2O.Specimens were sliced into 2-4mm sections and fixed for an 
additional 4-6 hours at 4⁰C. Samples were rinsed 5x 3min with cold cacodylate 
buffer containing 2mM CaCl2. Subsequently, specimens were incubated with 1% 
osmium ferricyanide for 18h, at 4⁰C and rinsed 5x in deionized water. This was 
followed by a 30min incubation in 1% thiocarbohydrazide at RT followed by 5 rinses 
in dH2O. Tissues were than incubated in 1% uranyl acetate in 0.05 maleate buffer 
at pH 5.5 and at 4°C overnight. After 5 washing steps for 3min with dH2O at RT, 
specimens were dehydrated via a graded series of alcohol (50%, 70%, 90%, and 
100%, ethanol) followed by incubation in dry ethanol, dry acetone and dry 
acetonitrile. Finally, samples were infiltrated with a Quetol 651 epoxy resin over a 
period of 5 days. The resin was cured for 48h at 65 ⁰C. Thin sections were prepared 
with a Leica Ultracut S mounted on 200 mesh copper grids and viewed with a Tecnia 
G2 operated at 200kV. 
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3.2.4.4 Micro computer tomography (µCT) 
Ex vivo μCT imaging of femurs and skulls was performed using a nanoPET/CT small 
animal imaging system (Bioscan, Washington DC) equipped with a micro-focus X-
ray source and a high-resolution radiation-imaging device featuring a 1024x3596 
pixel photodiode array with a 48μm pixel pitch. For CT measurements, scan 
parameters were 360 projections/rotations, 45kV (peak) 145μA current, and a 
detector pixel size of 71μm. Acquisition and reconstruction were performed with 
proprietary Nucline software (Mediso, Budapest, Hungary). 
3.2.4.5 Enzyme-Linked Immunosorbent Assay (ELISA) 
Cxcl12 protein levels were measured by conventional ELISA from BM extracellular 
fluid or BM stromal cell line supernatants (Fig. 7). Briefly, 96-well plates were coated 
overnight at 4ºC with 2μg/ml of monoclonal Cxcl1212/Sdf-1 antibody (MAB350, R&D 
Systems). After blocking with 3% sucrose/1% BSA/PBS, BM extracellular fluids 
were incubated in the Cxcl12 antibody-coated dishes for 2h at RT. 3 washing steps 
with 0.05% Tween20/PBS were accomplished and were followed by 2h incubation 
with a biotinylated anti-human/mouse Cxcl12/Sdf-1 antibody (BAF310, R&D). 
Streptavidin-conjugated horseradish peroxidase (HRP) (RPN1231V, Dako) was 
used to detect the antibody-binding to Cxcl12 by converting its substrate TMB 
(Tetramethylbenzidine, ES001-500ML, Chemicon, Millipore) into a colourful blue 
precipitate. Enzymatic reaction was stopped with hydrochloric acid (HCl) 1N. 
Absorbance at 450nm was measured photometrically to determine the Cxcl12 
content in the samples relative to a standard curve with recombinant Cxcl12 (350-
NS, R&D). 
 
Figure 7. Experimental design used for cell culture and Cxcl12 ELISA. 
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ELISA for detecting noradrenaline (Bi-CAT ELiSA, 17-BCTHU-EO2.1, ALPCO), 
acetylcholinesterase activity (MAK119, Sigma), TRAP (SB-TR103, IDS) and DPD 
(Quidel) were performed according to the manufacturer’s recommendations (see 
Table 5). 
3.2.5 Molecular biological methods 
 
3.2.5.1 Genotyping polymerase chain reaction (PCR) 
Mice genotype was determined from tail/ear biopsies obtained when weaning. 
Tissue digestion was performed with proteinase K (Sigma) diluted (1/40) in 500µl 
lysis buffer (50mM NaCl + 50mM Tris-KCl pH8 + 5mM EDTA + 0.2% SDS). Samples 
were allowed to digest in the thermomixer at 55ºC and 750 rpm overnight. 
The following day DNA extraction was performed. Samples were spin 5min at 13000 
rpm and non-digested debris was discarded transferring the supernatant to new 
tubes. For DNA precipitation 500µl isopropanol was added and mixed gently with 
the supernatant. Samples were spin again 5min at 13000 rpm to get DNA pellet. 
Supernatant was discarded carefully and 500µl ethanol 70% added to wash DNA 
pellet. After a last spinning for 5min at 13000 rpm. DNA pellet was resuspended in 
500µl TE buffer (1M Tris-HCl + 0.5M EDTA in distilled water). After 5min incubation 
at 55ºC and 750 rpm in the thermomixer, samples were ready for polymerase chain 
reaction (PCR). Extracted DNA was mixed with REDTaq ReadyMix PCR Reaction 
Mix (Sigma), 100µm oligonucleotides and nuclease-free water to run PCR. The PCR 
reaction mix and primer sequences used for genotyping PCR are shown in Table 9 
and Table 10, respectively. 
Table 9 Genotyping PCR reaction mix 
 
REAGENT VOLUME PER SAMPLE (µl) 
REDTaq ReadyMix PCR Reaction Mix  12.5 
dH2O 8.5 
Oligonucleotides mix 2 
Extracted DNA 2 
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Table 10 Genotyping primer sequences 
PRIMER NAME SEQUENCE (5‘-3‘) 
Gfra2. P1 CACATACACACAAAACTGTGGG 
Gfra2. P2: ATTCGCAGCGCATCGCCTTC 
Gfra2. P3: ATGTTGGAAGTCTCCTTCTC 
GFP. P1 ATCATGGCCGACAAGCAGAAGAAC 
GFP. P2 GTACAGCTCGTCCATGCCGAGAGT 
Adrb2. P1 AGGGGCACGTAGAAAGACAC 
Adrb2. P2 ACCAAGAATAAGGCCCGAGT 
Adrb2. P3 GAGACTAGTGAGACGTGCTACT 
Adrb3. P1 CGCATCGCCTTCTATCGCCTTCTTG 
Adrb3. P2 GTTGCGAACTGTGGACGTCAGTGG 
Adrb3. P3 ATTGCCGTTGGCGCTTAGCCAC 
Chrna7. P1 TTCCTGGTCCTGCTGTGTTA 
Chrna7. P2 ATCAGATGTTGCTGGCATGA 
Chrna7. P3 CCCTTTATAGATTCGCCCTTG 
Cre. P1 AATGCTTCTGTCCGTTTGCCGGT 
Cre. P2 CCAGGCTAAGTGCCTTCTCTACA 
tdTomato. P1 AGCAAGGGCGAGGAGGTCATC 
tdTomato. P2 CCTTGGAGCCGTACATGAACTGG 
 
3.2.5.2 RNA isolation, reverse transcription and Real time (RT) 
quantitative polymerase chain reaction (qPCR) 
Total RNA extraction was performed mixing resuspended cells with 500µl of TRIzol 
(Invitrogen) and 100µl of chloroform. After 10min samples were spin at 4ºC for 
15min (12.000 RCF). The nucleic acid fraction (top aqueous layer) was recovered 
and RNA precipitation was performed adding 250µl of isopropanol and letting 
samples to stand for 10min at room temperature. Samples were spin at 4ºC for 
15min (12.000 RCF) and RNA pellet was later washed with 1000µl 80% ethanol. 
Later samples were spin again at 4ºC for 15min (7500 RCF) to remove the 
supernatant and leave the washed RNA pellet in the bottom of the tube. To eliminate 
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contaminating genomic DNA, DNase treatment with RNase-free DNase Set 
(Qiagen) was included in the protocol. RNA pellet was incubated with 87.5µl 
nuclease free water and 10µl RDD buffer (Qiagen). After 10min, 2.5µl DNAse were 
added and mixed up with RNA suspension. DNAse was allowed to work for 10min 
at room temperature. RNA was further purified with RNeasy Mini Kit (Qiagen) 
following the manufacturer’s recommendations.  
For low cell numbers (<100.000), RNA was isolated using the Dynabeads® mRNA 
DIRECT™ Micro Kit (Invitrogen) according to manufacturer’s instructions.  
Table 11 RT-qPCR primer sequences 
 
RNA concentration was determined with NanoDrop Spectrophotometer (Thermo 
Scientific). A maximum of 2µg RNA was used for the reverse transcription using the 
Reverse Transcription System (Applied Biosystems), following the manufacturer’s 
recommendations. Absolut gene expression levels were determined by RT qPCR 
(Applied Biosystems). The cDNA was mixed with 100µm oligonucleotides and 
SYBR Green master mix (Applied Biosystems) containing buffer, dNTPs, 
PRIMER SEQUENCE FORWARD (5‘-3‘) SEQUENCE REVERSE (5‘-3‘) 
Cxcl12  CGCCAAGGTCGTCGCCG TTGGCTCTGGCGATGTGGC 
Kitl CCCTGAAGACTCGGGCCTA CAATTACAAGCGAAATGAGAGCC 
Chrna3 ACTCCAAAAGCTGCAAGGAA CAGAGCAGACAGGGACAACA 
Chrna4 GCAGGGTCTCACAGGAAGAG ACAGGATTTGGCTCCATCAC 
Chrna5 CGCTCTTCTTCCACACACAA TCTCGTGATGTAGCGAATGC 
Chrna7 TTGTGCTGCGATATCACCAC TTCATGCGCAGAAACCATGC 
Chrnb2 GGGAAGATTATCGCCTCACA GTGCAGTTCTGCTGGTCAAA 
Chrnb4 GCTGAAGCTACGTCCACCTC GAAGCTGACGCCCTCTAATG 
Chrm1 CAGAAGTGGTGATCAAGATGCCTAT GAGCTTTTGGGAGGCTGCTT 
Chrm2 TGGAGCACAACAAGATCCAGAAT CCCCTGAACGCAGTTTTCA 
Chrm3 CCGCTCTACCTCTGTCCTTCA GGTGATCTGACTTCTGGTCTTGAG 
Chrm4 GTGACTGCCATCGAGATCGTAC CAAACTTTCGGGCCACATTG 
Chrm5 GGCCCAGAGAGAACGGAAC TTCCCGTTGTTGAGGTGCTT 
Gapdh TGTGTCCGTCGTGGATCTGA CCTGCTTCACCACCTTCTTGA 
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thermostable hot-start DNA polymerase and SYBR Green dye. The expression level 
of each gene was determined by the relative standard curve method, using a 
standard curve prepared from serial dilutions of a mouse or human reference total 
RNA (Clontech).  
The expression level of each gene was calculated by interpolation from the standard 
curve. All values were normalised to Gapdh as the endogenous control. The primer 
sequences used for RT-qPCR are shown in Table 11. 
3.2.5.3 RNA sequencing 
Whole transcriptome sequencing was performed to compare gene expression 
profiles in Gfra2+/- and Gfra2-/- HSCs isolated from endosteal and non-endosteal 
compartments. Pools of 30 viable LSK CD48-CD150+ cells were sorted (BD Influx™ 
cell sorter) into 4μl lysis buffer (0.5U/μl SUPERase In RNase Inhibitor in 0.2% (v/v) 
Triton-X-100) containing 12.5mM DTT and 2.5mM dNTP.  
RNAseq was performed following the Smart-seq2 protocol (Picelli et al., 2014). 
Briefly, RNA was primed with oligo-dT primers and reverse transcribed using 
Superscript II Reverse Transcriptase (200U/μl, ThermoFisher 18064071). KAPA 
HiFi Hotstart ReadyMix (KAPA Biosystems, KK2601) and IS PCR primers were 
used to amplify  the cDNA, later purified with Agencourt AMPure XP beads 
(Beckman Coulter, A63881). cDNA quality was checked with Agilent Bioanalyser 
2100 using Agilent High Sensitivity DNA chip and quantity was measured with 
Quant-iT™ Picogreen double stranded DNA assay kit (Thermo Fisher P7589).  
Pooled libraries of 4 replicates per sample were prepared using the Illumina Nextera 
XT DNA preparation kit. Amplified libraries were purified using Agencourt AMPure 
XP beads, quality-checked using Agilent high-sensitivity DNA chip on Agilent 
Bioanalyser 2100 and quantified using KAPA qPCR quantification kit (KAPA 
Biosystems, KK4824). Sequencing was performed on the Illumina Hi-Seq 4000 
(single end, 50bp read length) by the CRUK Cambridge Institute Genomics Core 
facility.  
RNA-seq reads were aligned to the Mus musculus genome (Ensembl version 38.81) 
using GSNAP (version 2015-09-29) with parameters (-B 5 –t 24 –n 1 –Q –N 1). 
Reads in features were counted with htweqcount (HTSeq version 0.5.3p3) with the 
parameter (-s no). Quality control was performed with the following cut-offs: more 
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than one and a half million uniquely mappable reads, less than 20% of reads 
mapping to mitochondrial genes over mitochondrial + nuclear genes and more than 
8500 high coverage genes identified. Counts were normalized using size factors 
calculated by DESeq2 protocol using a 10% FDR. Values were then represented in 
log10 scale. Highly variable genes were selected using the method described by 
Brennecke et al. PCA was then performed in R using the prcomp function 
(Brennecke et al., 2013).  
Gene set enrichment analyses (http://www.broadinstitute.org/gsea/index.jsp) were 
performed using a weighted statistic, ranking by signal to noise ratio, 1000 gene-set 
permutations, and a custom gene set database gene lists manually compiled from 
the literature, as previously described (Sanchez-Aguilera et al., 2014). 
3.2.6 Statistical analysis 
For calculation of sample sizes, the total cellularity and composition of the different 
cell populations was determined in peripheral blood and BM using a hematologic 
analyser (Abacus Junior Vet, Beckman Coultier) and a cell counter (CASYton, 
CASY systems). 
The compared groups were set similarly in all procedures. For each scenario we 
established the number of conditions (including at least one control condition) to test 
the hypothesis. Results were scored blindly. Data shown in figures are means ± 
SEM; n and p values are indicated in each single figure. 
For statistical analysis, One Way ANOVA and Bonferroni comparison were used for 
multiple group comparisons, and unpaired two-tailed t tests for two-group 
comparisons. The data met the assumptions of the tests. Significant statistical 
differences between groups were indicated as: * p < 0.05; ** p < 0.01; *** p < 0.001. 
Statistical analyses and graphics were carried out with GraphPad Prism 5 software 
and Microsoft Excel. 
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“Con la responsabilidad gestionamos lo que depende de nosotros, 
 la persecución de los objetivos que nos hemos marcado. 
Con la capacidad de aguante, gestionamos lo que no 
depende de nosotros, es decir, la adversidad” 
Toni Nadal 
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4 Results 
 
4.1 GDNF Family Receptor Alpha 2 Knock-out (KO) mouse 
(Gfra2-/-) as a model of peripheral parasympathetic deficiency 
Gfrα2 is a glycosylphosphatidylinositol-linked cell surface co-receptor which belongs 
to the GDNF receptor family together with Gfrα1, Gfrα3 and Gfrα4. Although all co-
receptors are anchored to and activate RET tyrosine kinase receptor, each co-
receptor preferentially binds to a different neurotrophic factor (GDNF/Gfrα1, 
Nrtn/Gfrα2, Artn/Gfrα3 and Pspn/Gfrα4). Nrtn/Gfrα2 signalling has been shown to 
be essential for development and maintenance of the enteric and parasympathetic 
nervous system (Heuckeroth et al., 1999; Rossi et al., 1999). Thus, we used a Gfra2-
/- mouse model to study a possible parasympathetic regulation of BM HSC niches. 
Measurement of acetylcholinesterase (AchE) activity in urine of Gfra2-/- and control 
mice indirectly confirmed the reduction of parasympathetic tone in Gfra2-/- mice (Fig. 
8A). However, the reduced parasympathetic activity did not affect the 
haematopoietic system as the numbers of BM nucleated cells and BM as well as 
spleen HSCs were not altered (Fig. 8B and 8C). 
 
Figure 8. Gfra2-/- mice exhibit decreased parasympathetic activity while 
haematopoietic numbers remain unaltered. A, AChE activity in urine samples 
collected at night from Gfra2-/- mice and control Gfra2+/- mice. B, Number of LIN-
SCA1+cKIT+CD150+CD41- HSCs in BM and spleen. C, BM nucleated cells in Gfra2-
/- mice and control Gfra2+/- mice (2 femurs). Data are means ± SEM; n and p values 
are indicated. * p < 0.05. 
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4.2 Circadian autonomic cholinergic regulation of HSC 
trafficking 
The autonomic nervous system controls the circadian circulation of HSPCs between 
the BM and other peripheral organs like the blood. Following exposure to light, 
sympathetic signals are transmitted to efferent nerve terminals in the BM where they 
induce the release of noradrenaline. Adrenergic stimulation of BMSCs decreases 
Cxcl12 levels and leads to HSPC egress during the day, reaching a peak at 
Zeitgeber time (ZT, hours after light onset) 5 (Mendez-Ferrer et al., 2008). Since the 
PNS antagonises sympathetic signals in many peripheral systems (Beauregard & 
Smith, 1994; Benthem, Mundinger, & Taborsky, 2001; Miyashita et al., 1999; Pendry 
& Maclagan, 1991), we decided to study the circadian HSPC trafficking in Gfra2-/- 
mice. Measurement of circulating HSPCs over 24h revealed normal circadian 
oscillations in control mice and in Gfra2-/- mice during the day period. However, 
circulating leukocytes and HSPCs were 2-3-fold increased at night (ZT13) (Fig. 9A). 
To analyse circulating HSCs in vivo, we performed long-term repopulation assays 
using limiting dilutions of blood harvested at ZT13 from Gfra2-/- and control mice. 
The number of HSCs in the bloodstream was similarly elevated 3-5 times in Gfra2-
/- mice at night (Fig. 9B). These results suggest a role for PNS in circadian regulation 
of HSC trafficking, specifically during the night time when HSPC homing to the BM 
is predominant (Fig. 9C). 
4.3 HSPC accumulation in peripheral blood in Gfra2-/- mice 
at night is not due to reduced HSPC BM homing 
Murine leukocytes and HSPCs preferentially home to the BM at night (Scheiermann 
et al., 2012). Thus, we investigated whether the observed accumulation of HSPCs 
in the blood of Gfra2-/- mice at night is caused by defective HSPC BM homing. We 
performed reciprocal BM transplantations using Gfra2-/- or control Gfra2+/- mice as 
donors as well as recipients as indicated in Fig. 10A. HSPC BM homing was similar 
in lethally-myeloablated mice in all conditions tested (Fig. 10B). Lethal irradiation 
increases BM homing efficiency but also induces damage of BM niches in recipient 
mice and thus might interfere with niche-dependent homing mechanisms (Green & 
Rubin, 2014). For this reason, we transplanted HSPC-enriched cells into non-
irradiated recipient mice (Fig. 10C). Surprisingly, HSPC BM homing was not 
reduced, but even increased in unconditioned Gfra2-/- mice (Fig. 10D). BM homing 
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was not affected when transplanting Gfra2-/- donor HSPCs into control Gfra2+/- 
recipients, suggesting that increased HSPC homing detected in Gfra2-/- mice is a 
non-cell autonomous defect. HSPC homing takes place in the BM sinusoids and 
HSC adhesion to sinusoids via integrins and selectins is an essential step in the BM 
homing process (Lapidot, Dar, & Kollet, 2005).  
 
Figure 9. HSPCs accumulate in peripheral blood of Gfra2-/- mice at ZT13. A, 
HSPCs, measured as CFU-Cs, and white blood cells (WBCs) in the peripheral blood 
of Gfra2-/- mice (green) and control Gfra2+/- mice (purple) harvested at the specified 
ZT. B, HSCs, measured by long-term competitive repopulation assay, in peripheral 
blood harvested at ZT13 from Gfra2-/- mice (green) and control Gfra2+/- mice 
(purple). The frequency of mice with failed reconstitution is plotted against the 
transplanted blood volume. Blood HSC concentrations are indicated (n = 5). C) 
Scheme illustrating our hypothesis about the role of PNS in HSPC traffic regulation. 
Data are means ± SEM; n and p values are indicated. * p < 0.05; *** p < 0.001. 
In order to study whether the increased accumulation of HSPC in the BM of Gfra2-/- 
mice was due to an increase in active BM homing, we treated the mice with 
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antibodies against integrin α4 (Papayannopoulou, Priestley, Nakamoto, 
Zafiropoulos, & Scott, 2001), E-selectin and P-selectin (Katayama et al., 2003) at 
night (Fig. 10E). Homing blockade abrogated nocturnal differences in circulating 
HSPCs between Gfra2-/- and control Gfra2+/- mice (Fig. 10F). In summary, HSPC 
homing to the BM is increased in Gfra2-/- mice, but does not contribute to HSPC 
accumulation in the bloodstream at night. 
 
Figure 10. Increased HSPC BM homing in Gfra2-/- mice. A, Scheme showing the 
protocol used for the HSPC BM homing assay with lethal irradiation. B, Frequencies 
of HSPCs (CFU-Cs) that homed to the BM 16h after reciprocal transplantation of 
Gfra2-/- or control Gfra2+/- BM cells into lethally irradiated Gfra2-/- or control Gfra2+/- 
mice. C) Scheme showing the protocol used for HSPC BM homing assay without 
irradiation. D, Frequencies of CD45.1+ Gfra2+/- or CD45.1+ Gfra2-/- HSPCs that 
homed to BM 16h after transplantation into non-irradiated CD45.1 or CD45.2 mice. 
E, Scheme showing the protocol used for homing blockade. F, HSPCs circulating at 
ZT13 5h after injection of blocking antibodies against integrin α4, P- and E-selectin 
(Abs) or control IgG. Data are means ± SEM; n and p values are indicated. * p < 
0.05; ** p < 0.01; *** p < 0.001. 
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4.4 PNS signals regulate HSC trafficking indirectly 
Despite the increased BM homing in Gfra2-/- mice, HSPCs intriguingly accumulated 
in the peripheral blood at night. Increased numbers of circulating HSPC suggested 
us that HSPC mobilisation might be similarly increased in our parasympathetic-
deficient mouse model at night. Since the SNS contributes to physiological HSC 
egress from the BM (Mendez-Ferrer et al., 2008; Spiegel et al., 2007) and enforced 
mobilisation by G-CSF (Katayama et al., 2006), we next studied sympathetic 
signalling in Gfra2-/- mice. 
For this purpose we quantified BM sympathetic fibres and measured the 
concentration of the sympathetic neurotransmitter noradrenaline in the urine of 
Gfra2-/- and control mice during the day and the night. Interestingly, TH+ fibres as 
well as nocturnal but not diurnal noradrenaline levels were increased in Gfra2-/- mice 
compared to control Gfra2+/- mice (Fig. 11A-D). Hence, the sympathetic tone is 
specifically increased during the night in parasympathetic-deficient Gfra2-/- mice. As 
it has been shown that PNS can modulate sympathetic activity in other systems 
(Gavioli et al., 2014), we hypothesized that increased parasympathetic activity might 
have an important inhibitory role during the night by dampening sympathetic tone 
and contributing to reduced HSPC egress in a setting when BM homing is the 
predominant process. 
To address this hypothesis and locate this possible inhibitory regulation, we treated 
wild-type mice during the night with acetylcholine antagonists that are blood-brain 
barrier permeable (mecamylamine) or non-permeable (atropine methyl nitrate). 
While mice treated with the non-permeable antagonist showed normal numbers of 
circulating HSPCs, those treated with blood-brain barrier-permeable drug exhibited 
a 3-fold increase of HSPCs in the blood (Fig. 11E). Thus, central cholinergic signals 
contribute to BM HSPC-trafficking during the night. 
To confirm the indirect cholinergic regulation of circadian HSPC trafficking via SNS 
modulation, we bred Gfra2-/- mice with mice lacking the main β-adrenergic receptors 
that cooperate during enforced mobilisation: β2- and the β3-adrenergic receptor 
(Mendez-Ferrer, Battista, & Frenette, 2010). Nocturnal circulating HSPCs and 
leukocytes were similarly increased in Gfra2-/- mice and Gfra2-/-;Adrb2-/- (Fig. 11F). 
In contrast, Gfra2-/-;Adrb3-/- mice recovered normal circulating HSPC numbers at 
night (ZT13) (Fig. 11G). In conclusion, central and nocturnal PNS signals interfere 
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with SNS innervating the BM and this results in HSPC trafficking regulation by 
inhibition of sympathetic activity transmitted by β3-adrenergic receptor. 
 
Figure 11. The PNS controls HSPC trafficking indirectly through central SNS 
regulation. A-B, IF staining of CD31+ endothelial cells (blue), tyrosine hydroxylase 
(TH)+ sympathetic nerve fibres (red) and Nes-GFP+ cells (green) in the skull BM of 
Nes-gfp;Gfra2-/- and control Nes-gfp;Gfra2+/- mice. Scale bar, 100µm. C, 
Quantification of BM sympathetic noradrenergic nerve fibres. D, Noradrenaline 
concentration in the urine of Gfra2-/- and control Gfra2+/- mice collected at night 
(black box) and day (yellow box). E, HSPCs circulating in the blood of C57BL/6 mice 
treated with mecamylamine, atropine methyl nitrate or vehicle (3mg/kg). F, HSPCs 
circulating at ZT13 in Gfra2-/- mice or compound mice deficient for Gfra2 and β2- or 
β3-adrenergic receptors. G, WBCs circulating at ZT13 in Gfra2-/- mice or compound 
mice deficient for Gfrα2 and β2- or β3-adrenergic receptors. C-F, Data are means ± 
SEM; n and p values are indicated. C, Unpaired two-tailed t test. D-G, One-way 
ANOVA and Bonferroni comparisons. * p < 0.05; ** p < 0.01. 
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4.5 Deregulated HSPC-trafficking in parasympathetic fibre 
deficient-mice is a non-cell autonomous effect 
In contrast to β-adrenergic receptors which are broadly expressed by 
haematopoietic cells, β-adrenergic receptor is mostly expressed in non-
haematopoietic cells (adipocytes, BMSCs and endothelial cells), indicating that the 
exacerbated sympathetic tone in Gfra2-/- mice most likely affects stromal cells in the 
BM microenvironment. However, RET, which mediates the downstream signalling 
upon Gfrα co-receptors binding to it respective ligand, has been shown to be 
expressed by HSCs. RET-signalling in HSCs promotes HSC survival, expansion 
and improves in vivo transplantation efficiency (Fonseca-Pereira et al., 2014). Thus, 
in addition to central SNS deregulation, defective RET signalling in HSPCs might 
contribute to increased HSPC egress in Gfra2-/-.  
To dissect the contribution of direct vs stromal cell mediated neural signals in 
regulating HSPC trafficking in Gfra2-/- mice, we generated chimeric mice through 
long-term reciprocal BM transplantations. Lethally-irradiated Gfra2-/- or control 
Gfra2+/- recipient mice were reciprocally transplanted with Gfra2-/- or control Gfra2+/- 
donor BM cells. This results in the generation of mice with Gfra2-/- haematopoietic 
cells and control BMSCs and vice versa. Control mice carrying Gfra2-/- 
haematopoietic cells had normal blood counts. In contrast, Gfra2-/- recipients 
transplanted with control haematopoietic cells exhibited nocturnal accumulation of 
circulating HSPCs and leukocytes in the blood (Fig. 12). These experiments strongly 
suggest that circadian HSPC trafficking defects in parasympathetic-fibre deficient 
Gfra2-/- mice are mediated by the BM stromal compartment rather than HSPCs 
directly. 
The chemokine Cxcl12 is the master regulator of HSC function in BM niches. 
Multiple studies have shown its role in controlling HSC quiescence as well as HSPC 
migration/retention (Greenbaum et al., 2013; Nagasawa et al., 1996). Interestingly, 
circadian oscillations of circulating HSPCs correlate with anti-phase fluctuations in 
BM Cxcl12 expression (Mendez-Ferrer et al., 2008; Schajnovitz et al., 2011). Based 
on this knowledge we reasoned that Cxcl12 might be affected in parasympathetic 
fibre-deficient Gfra2-/- mice. We measured Cxcl12 gene expression levels over 24h 
and detected a significant decrease at ZT13 (Fig. 13A). Importantly, this reduction 
of Cxcl12 at transcriptomic level was accompanied by a decrease at protein level 
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(Fig. 13B). Thus, we found that nocturnally increased numbers of circulating HSPCs 
and leukocytes correlate with a Cxcl12 reduction at the same circadian time in Gfra2-
/- mice. 
 
Figure 12. HSPC-trafficking defect in Gfra2-/- mice results from neural 
deregulation of the BM microenvironment. A-B, HSPCs, measured as CFU-Cs 
(A) and WBCs (B) circulating in the blood at ZT13, 16 weeks after reciprocal BM 
transplantations in lethally-irradiated mice. Gfra2-/- mice and control Gfra2+/- mice 
were used as donor or recipients. Data are means ± SEM; n and p values are 
indicated. One-way ANOVA and Bonferroni comparisons. * p < 0.05; ** p < 0.01. 
 
Figure 13. Reduced Cxcl12 level in Gfra2-/- mice at ZT13. A, Cxcl12 mRNA 
expression in the BM of Gfra2-/- and control Gfra2+/- mice at the specified ZT. B, 
Cxcl12 protein concentration in BM extracellular fluid (BMECF). Data are means ± 
SEM; n and p values are indicated. A, Multiple two-tailed t test. B, Unpaired two-
tailed t test. * p < 0.05. 
Cxcl12 is highly expressed and released in BM niches by multiple cell types 
including osteoblasts and different BMSCs (NG2+ perivascular cells, Lepr+ cells, 
CAR cells and nestin+ cells) (Fig. 3). Interestingly, BM sinusoids, which are the most 
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permeable vessels through which HSPCs traffic in and out of the BM (Itkin et al., 
2016), are surrounded by Nes-GFPloLepr+ BMSCs. This perisinusoidal BMSC 
population controls HSC maintenance by secreting Cxcl12, but specially Scf (Ding 
et al., 2012). In contrast, Nes-GFPhiNG2+ BMSCs are associated with less 
permeable arteriolar-like vessels (Kunisaki et al., 2013) as well as TZ vessels in 
endosteal areas (Kusumbe et al., 2014) and secrete mainly Cxcl12. This together 
with the fact that nestin+ BMSCs can respond to sympathetic signals via β3-
adrenergic receptor signalling encouraged us to study the role of nestin+ cells as 
BMSCs mediating the Gfra2-/- phenotype. 
The global number of Nes-GFP+ cells with in the BM was not changed in Gfra2-/- 
mice compared to control mice (Fig. 14A). To have a closer look at different 
subpopulations of nestin+ cells including sinusoidal Nes-GFPlo cells and non-
sinusoidal Nes-GFPhi cells in Nes-gfp;Gfra2-/- mice, we mechanically separated BM 
fractions as previously shown (Grassinger & Nilsson, 2011) (see Fig. 5). This 
technique, allows the efficient separation of an endosteal fraction from a non-
endosteal and sinusoidal cell-enriched fraction. 
The Nes-GFPhi population was more abundant in the endosteal compartment in 
which nestin+ cells have been described to be closely associated with TZ vessels 
(Kusumbe et al., 2016), validating our method for separating endosteal and non-
endosteal fractions. In fact, Nes-GFPhi cells associated with arteriolar vessels 
remained attached to endosteal structures after BM flushing (Fig. 14B,D). Nes-
GFPlo cells were more abundant in non-endosteal compartment. Whereas the Nes-
GFPhi cell number was comparable between Gfra2-/- and control mice, Nes-GFPlo 
cells were reduced by 40% in non-endosteal fraction of Gfra2-/- mice (Fig. 14C). 
Since sinusoidal Nes-GFPlo cells constitute the vast majority of nestin+ in the BM, 
the decrease of Nes-GFPlo cells may explain the reduced Cxcl12 level in Gfra2-/- 
mice (Fig. 13). Nes-GFPlo cell number reduction might also result from the increased 
sympathetic activity in parasympathetic deficiency, since noradrenaline has been 
shown to inhibit Nes-GFP+ cell proliferation (Mendez-Ferrer, Michurina, et al., 2010).  
This suggests that impaired cholinergic signalling in parasympathetic fibre-deficient 
Gfra2-/- mice leads to increased sympathetic activity, which reduces sinusoidal 
HSPC maintenance by decreasing Nes-GFPlo cell numbers and Cxcl12 level. As 
consequence HSPC trafficking through sinusoids is over-activated in Gfra2-/- mice. 
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Figure 14. Nes-GFPlo cell numbers are reduced in the non-endosteal 
compartment of Gfra2-/- mice. A, Nes-GFP+ BMSC numbers in Gfra2-/- and control 
mice. B, Representative flow cytometry profiles of non-endosteal GFP+CD45-CD31-
Ter119- BMSCs obtained by flushing out the BM of long bones and of endosteal 
GFP+ BMSCs in the remaining in long bones of adult Nes-gfp mice. Both cell 
fractions were digested with collagenase. C, Stromal Nes-GFPlo/hi cells in endosteal 
and non-endosteal BM of Gfra2-/- and control mice. D, Images illustrating the high 
enrichment of Nes-GFPhi cells in the bone-associated fraction of flushed Nes-GFP+ 
bones. Scale bar, 200 µm. A, Unpaired two-tailed t test. C, One-way ANOVA and 
Bonferroni comparisons. A, C, Data are means ± SEM; n and p values are indicated. 
* p < 0.05; *** p < 0.001. 
 
4.6 PNS independently regulates HSPC trafficking and 
bone formation 
Whereas the evidence for parasympathetic regulation of the BM is scarce, several 
studies have reported the involvement of the PNS in the bone formation process. In 
this context, cholinergic fibres have been reported to directly transmit bone anabolic 
signals from the brain (Bajayo et al., 2012). However, the PNS has also been 
proposed to regulate bone formation indirectly by modulating the sympathetic tone 
centrally (Shi et al., 2010). Based on these initial studies, we investigated whether 
bone remodelling is affected in parasympathetic-deficient Gfra2-/- mice and whether 
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this interferes with the HSPC trafficking defect. Considering that PNS activity was 
shown to promote bone formation, we checked the number of osteoprogenitor cells 
in Gfra2-/- mice. 
 
Figure 15. Deregulated osteoprogenitor activity in Gfra2-/- mice. A, 
Quantification of BM CFU-fibroblast (CFU-F) and –osteoblast (CFU-OB) from Gfra2-
/- and control Gfra2+/- mice. B, Representative images of CFU-F and CFU-OB 
colonies. A, Data are means ± SEM; n and p values are indicated. One-way ANOVA 
and Bonferroni comparisons. * p < 0.05. 
In vitro CFU-C assays showed that both fibroblastic (CFU-F) and osteoblastic (CFU-
OB) progenitors were significantly increased in BM from Gfra2-/- compared to control 
mice (Fig. 15). Increased osteoprogenitor activity most likely represents a 
compensatory response to previously described impaired bone growth in Gfra2-/- 
mice (Rossi et al., 1999). Further characterization of bones from Gfra2-/- mice by 
micro computed tomography (µCT) and bone immunofluorescence revealed 
enlarged cranial sutures and decreased trabecules in Gfra2-/- mice (Fig. 16A-D). 
However, markers of bone resorption such as tartrate-resistant acid phosphatase 
(TRAP) and deoxypyridinoline (DPD) cross-linking levels in urine were not altered 
in Gfra2-/- mice suggesting that bone defects observed were not caused by 
increased osteoclastic activity (Fig. 16E,F) 
Importantly, intercellular contact between bone-embedded osteocytes has been 
suggested to be required for sympathetic fibre-mediated HSPC mobilisation in 
response to granulocyte colony-stimulating factor (G-CSF) administration (Asada et 
al., 2013). To investigate whether altered sympathetic activity and bone remodelling 
in Gfra2-/- mice could be related to defective osteocyte cell contact formation, we 
labelled F-actin elements in the cytoskeleton of osteocytes by phalloidin staining. 
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Phalloidin staining revealed that osteocyte projections were markedly reduced in 
Gfra2-/- mice compared to control mice, indicating that bone remodelling is defective 
in these mice (Fig. 17A-B). In consequence, we dissected whether the HSPC 
trafficking defect observed in Gfra2-/- mice was rather a direct consequence of the 
bone phenotype or an independent alteration caused by parasympathetic 
deficiency. Intravital microscopy analysis showed that vascular integrity was intact 
in Gfra2-/- mice (Fig. 17C). Gfra2-/- mice and control mice were treated with the 
mobilising agent G-CSF and circulating HSPCs were measured. Mobilisation was 
similar in both groups, suggesting that HSPC trafficking alteration and bone defects 
are independent phenotypes present in parasympathetic-deficient Gfra2-/- mice (Fig. 
17D). 
 
Figure 16. Bone defects in Gfra2-/- model are not caused by increased bone 
resorption. A-C, µCT of femoral trabecular bone area (A-B) and skull (C) from 
Gfra2-/- and control Gfra2+/- mice. Arrows indicate enlarged cranial sutures and 
ossification defects. D, Quantification of trabecular bone area. E-F, Osteoclast 
activity measured in Gfra2-/- and control Gfra2+/- mice in the night by determining 
urine concentration of tartrate-resistant acid phosphatase (TRAP) (E) and by 
performing deoxypyridinoline (DPD) cross-link test (F). D-F, Data are means ± SEM; 
n and p values are indicated. Unpaired two-tailed t test. * p < 0.05. 
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In conclusion, although cholinergic signals contribute to modulate both HSPC 
trafficking and bone remodelling processes, this regulation seem to be mediated by 
different mechanisms in Gfra2-/- mice. 
 
Figure 17. Decreased osteocyte projections is not associated with HSPC 
traffic defect in parasympathetic-deficient Gfra2-/- mice. A-B, Phalloidin staining 
of osteocyte actin skeleton (green) (A) and quantification of phalloidin+ area (B). 
Scale, 25 µm. C, Intravital microscopy of the skull BM 5min after intravenous 
injection of TRITC-Dextran (red). Scale, 100 µm. D, HSPCs circulating at ZT13, 5h 
after the last injection of G-CSF (8 doses of 125 µg/kg every 12h). B-C, Data are 
means ± SEM; n and p values are indicated. Unpaired two-tailed t test. ** p < 0.01. 
4.7 Cholinergic nerve fibres innervate bone and endosteal 
BM 
The first part of this thesis has shown the importance of central cholinergic signalling 
in regulating circadian HSPC trafficking through modulation of SNS activity. The 
PNS has been similarly suggested to promote bone formation by antagonising 
central sympathetic signals (Shi et al., 2010). Similarly, our data supports a 
parasympathetic regulation of HSPC trafficking at the central level. Experiments with 
blood-brain barrier permeable and non-permeable acetylcholine antagonists placed 
the inhibitory modulation of sympathetic activity by parasympathetic fibres inside of 
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the CNS (Fig. 10E). However, these experiments cannot rule out the possibility that 
cholinergic fibres might also directly innervate the BM and regulate BM niches 
locally. 
Despite some immunohistochemistry studies suggesting the presence of cholinergic 
fibres in the BM (Artico et al., 2002), the existence of these fibres have not been 
validated and thus remains unclear. In contrast of the scarce neuroanatomical 
evidence, parasympathetic innervation in the BM has been reported to transmit 
bone anabolic signals from the brain (Bajayo et al., 2012). In this work authors used 
vesicular acetylcholine transporter (VAChT) as a marker to label skeletal PNS fibres 
in the bone. VAChT is a membrane transporter which loads acetylcholine into 
secretory organelles and has been used as specific maker of synaptic vesicles in 
PNS terminals (Weihe, Tao-Cheng, Schafer, Erickson, & Eiden, 1996). 
To study the possible innervation of the BM by cholinergic fibres, we immunostained 
WT whole-mount bone samples for VAChT. As previously reported, VAChT+ fibres 
were found at the outer surface of the bone (periosteum) (Asmus et al., 2000). We 
also detected some cholinergic fibres in the bone proper and at the inner surface of 
the bone (endosteum), which is in close contact with the BM (Fig. 18). VAChT is not 
the only marker used to identify cholinergic fibres and the enzyme choline 
acetyltransferase (ChAT) has also been used to mark cholinergic fibres in the rat 
BM (Artico et al., 2002). To confirm the presence of cholinergic nerve fibres in the 
murine endosteal BM we used ChAT-IRES-cre mice (Rossi et al., 1999) 
intercrossed with Ai35D reporter mice (Madisen et al., 2012). In this mouse model, 
Cre-mediated recombination in cholinergic neurons renders them GFP+. ChAT-
IRES-cre;Ai35D mice revealed the presence of ChAT+ fibres in the skull BM and in 
long bones of WT mice. Similar to VAChT staining, ChAT-labelled structures were 
always associated with the endosteal compartment in the BM (Fig. 19).  In contrast 
to WT mice, endosteal VAChT+ cholinergic fibres were undetectable in 
parasympathetic-deficient Gfra2-/- mice (Fig. 20A-C). Given the small size and the 
fact that this is the first time this innervation has been reported in the BM, we 
performed transmission electron microscopy to further characterize it. In this 
detailed analysis, unmyelinated axons (compatible with the cholinergic phenotype) 
were present in the endosteal bone of WT mice, while reduced in Gfra2-/- mice (Fig. 
20D-E). 
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Figure 18. Vesicular acetylcholine transporter (VAChT) labels cholinergic 
fibres in the bone and endosteal BM. Immunofluorescent staining for VAChT to 
label cholinergic nerve fibres (green) in adult diaphyseal BM (A-C) or epiphyseal BM 
(D-E) sections of C57Bl/6 mice. Bone (blue) was visualised by second harmonic 
collagen signals. Endomucin (red) helped to visualize the vasculature in epiphyseal 
BM. Nuclei were counterstained with DAPI (grey). Endosteal surface is depicted by 
a dashed line. Close-ups of A and D are shown in A’ and D’ respectively. Scale bar, 
100 µm. 
In conclusion, using several different approaches we confirmed the presence of 
autonomic cholinergic innervation in bone proper and, more interestingly, in the 
endosteal BM which was drastically reduced in Gfra2-/- mice. 
4.8 A sympathetic origin for cholinergic fibres in the BM 
Although noradrenaline is the primary postsynaptic neurotransmitter of the SNS, 
some exceptions to this rule have been reported. During development, some 
peripheral sympathetic neurons releasing noradrenaline start producing 
acetylcholine, thereby becoming sympathetic cholinergic neurons (Francis & 
Landis, 1999). This phenomenon was named “cholinergic switch” (Wolinsky & 
Patterson, 1983) and has been described in at least three different structures, 
including sweat glands, vasculature in skeletal muscle and periosteum. Importantly, 
sympathetic cholinergic neurons require Gfrα2 signalling for survival, being 
completely absent in the periosteum of Gfra2-/- mice (Hiltunen & Airaksinen, 2004). 
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Figure 19. Choline acetyltransferase (ChAT)-traced and VAChT-stained neural 
fibres innervate bone and endosteal BM. Immunofluorescence of VAChT to label 
cholinergic nerve fibres (green) and anti-GFP (red) in adult femoral BM sections (A-
D) or skull BM (E) of ChAT-IRES-cre;Ai35D mice with GFP expression in 
genetically-traced cholinergic neurons. Endosteal surface is depicted by a dashed 
line. Nuclei were counterstained with DAPI (blue). A’ shows a close-up of A. Scale 
bar, 100 µm. 
The cholinergic switch occurs early postnatally around week 1-3 (Asmus et al., 
2000). We performed chemical sympathectomy with 6-OHDA during the first 
postnatal days because this treatment targets sympathetic fibres that would later 
become cholinergic (at the time when they are still adrenergic). We followed this 
approach to determine if endosteal VAChT+ fibres are sympathetic, like those 
previously reported in the periosteum, or parasympathetic. For this purpose, 
neonatal mice were treated with 6-OHDA during the first postnatal week and the BM 
innervation was analysed in the same mice at adulthood (Fig. 21A). Postnatal 6-
OHDA treatment ablated not only adult sympathetic noradrenergic fibres (“normal 
sympathetic fibres”), but also the majority of adult VAChT+ fibres. This result 
indicates that endosteal and periosteal VAChT+ fibres correspond to sympathetic 
cholinergic neurons (Fig. 21B-C). 
In order to confirm the sympathetic origin of endosteal VAChT+ fibres and to analyse 
their relationship with sympathetic noradrenergic fibres, we took advantage of the 
Th-cre;Ai14D mouse model. Since the Cre-recombinase is activated when the TH 
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enzyme is expressed in the neuron, this mouse model has genetically-labelled 
Tomato+ neurons that synthesize or have synthesized noradrenaline at some point. 
Thus, fibres with sympathetic origin, including sympathetic cholinergic fibres, are 
labelled in this model. Immunostaining of whole mount femur samples of Th-
cre;Ai14D mice revealed the presence of VAChT+Tomato+ double positive fibres, 
confirming the sympathetic origin of VAChT+ fibres (Fig. 22A-D). 
 
Figure 20. VAChT+ cholinergic fibres are dramatically reduced in Gfra2-/- mice. 
A-C, Immunofluorescent staining of VAChT to label cholinergic fibres (green) in 
adult femur sections of Gfra2-/- mice. Bone (blue) is visualised by second harmonic 
collagen signals and nuclei are counterstained with DAPI (gray). Endosteal surface 
is depicted by a dashed line. D-E, Transmission electron microscopy images of 
control Gfra2+/- (D) and Gfra2-/- (E) bones. The arrow depicts a non-myelinated fibre. 
Scale bar, 100 µm. 
Analysis of the relative position of sympathetic cholinergic fibres with respect to 
other fibres revealed close association of sympathetic cholinergic fibres with 
TH+vAChT- sympathetic noradrenergic fibres as well as Schwann cells (genetically-
labelled using a Dhh-cre;Ai14D mouse model) (Fig. 22E-J). Therefore, 
postganglionic regulatory feedback loops might be in place at the peripheral level to 
control the final neural output regulating the BM HSPC niche. 
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Figure 21. Cholinergic fibres innervating bone and endosteal BM have a 
sympathetic origin. A, Scheme showing the protocol used for neonatal 
sympathectomy using 6-OHDA (100 mg/kg diluted in 0.2% ascorbic acid in 0.9% 
NaCl, s.c. on alternate days). B, Immunofluorescent staining for VAChT+ cholinergic 
nerve fibres (green) in femoral BM (upper panels) or skull BM (lower panels) from 
adult C57Bl/6 mice, which were previously treated with 6-OHDA or saline at 
neonatal stages. Bone (blue) was visualised by second harmonic collagen signals. 
Nuclei were counterstained with DAPI (gray). Scale bar, 100 µm. C, Quantification 
of VAChT+ fibres in C57Bl/6 mice treated with saline or 6-OHDA. Data are means ± 
SEM; n and p values are indicated. Unpaired two-tailed t test. *** p < 0.001. 
4.9 Sympathetic cholinergic innervation might contribute 
to maturation of the perinatal BM niche 
Although BM niche colonisation by HSCs starts at late stages of embryonic 
development, HSC migration from the liver to the BM persists early postnatally 
(Wolber et al., 2002). During this period the BM stroma still undergoes maturation 
and becomes vascularised as well as innervated (Gajda et al., 2000). Because the 
cholinergic switch takes place during these first postnatal days, we analysed 
whether the absence of sympathetic cholinergic fibres in Gfra2-/- mice had any 
relevance in BM HSC colonisation. 
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Figure 22. Sympathetic noradrenergic and sympathetic cholinergic fibres run 
closely in periosteal locations. A-F, Immunofluorescent staining of VAChT+ fibres 
(green) in adult femur BM (A-E) and skull BM (F) of Th-cre;Ai14D mice with 
genetically-labelled TH+ sympathetic neurons (red). Bone (blue) was visualized by 
secondary harmonic signals from collagen (E). Blood vessels were stained with 
CD31 (F). G-J, Immunofluorescent staining of VAChT+ fibres (green) in adult femur 
of Dhh-cre;Ai14D mice with genetically-labelled Schwann cells (red). Endosteal 
surface is depicted by a dashed line. Nuclei were counterstained with DAPI (gray). 
Scale bar, 100 µm. 
While HSC numbers were normal in the FL of Gfra2-/- embryos before birth, we 
detected a severe reduction of HSCs in the BM one week after birth (Fig. 23 A-C). 
This was accompanied by a 3-fold-decrease in BM Cxcl12 gene expression, 
whereas Scf expression remained unchanged (Fig. 23D). Considering that Cxcl12 
is key to HSC attraction from the FL and colonisation of the BM (Isern et al., 2014), 
these results suggest that sympathetic cholinergic fibres contribute to 
developmental BM HSC niche maturation in early postnatal life. 
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Figure 23. Developmental switch of neurotransmitter might contribute to BM 
HSC niche maturation. A, Foetal liver (FL) HSC numbers of Gfra2-/- and control 
Gfra2+/- mice at E17.5. B, BM HSC numbers in 1-week old (P7) Gfra2-/- and control 
Gfra2+/- mice. C, Representative flow cytometry diagrams of BM LIN-SCA1+cKIT+ 
(LSK) HSPCs from 1-week-old Gfra2-/- and control Gfra2+/- mice. D, Cxcl12 and Kitl 
mRNA expression (qPCR) in BM of P7 Gfra2-/- and control mice. Data are means ± 
SEM; n and p values are indicated. Unpaired two-tailed t test. * p < 0.05. 
4.10 Sympathetic cholinergic nerve fibres target Nes-GFPhi 
BMSCs in endosteal BM niches 
The postnatal HSC reduction in the BM of Gfra2-/- mice is restored during adulthood 
(Fig. 8B). Restoration of HSC numbers might result from an increase in HSC 
proliferation to balance the low postnatal HSC numbers, or it might even suggest 
that cholinergic fibres negatively regulate HSC proliferation (coinciding with the 
endosteal location where HSC quiescence in enforced). Physiological postnatal BM 
colonisation involves a drastic reduction of HSC proliferation in a Cxcl12-dependent 
manner (Bowie et al., 2006; Williams, Xu, & Cancelas, 2006). Intriguingly, this 
dramatic change of HSC proliferation coincides in time with the cholinergic switch 
maturation. Taking into account the unbalanced HSC numbers and Cxcl12 levels in 
Gfra2-/- mice, we hypothesized that sympathetic cholinergic fibres could promote 
HSC quiescence signals and that their absence might increase HSC proliferation. 
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Figure 24. VAChT+ fibres innervate Nes-GFPhi cells in endosteal BM niches. A-
H, Endogenous GFP signal (green) and immunofluorescence for VAChT to mark 
cholinergic nerve fibres (red) in femoral BM section from representative adult Nes-
gfp mice. Nuclei were counterstained with DAPI (gray). Scale bar, 100 µm. 
In adult mice, sympathetic cholinergic fibres were found in close association with 
bone surfaces (Fig. 18 and 19). The inner bone surface-endosteum plays an active 
role in HSC quiescence and maintenance through multiple cells including 
osteoblasts and endosteal macrophages. Endosteal niches have been found to be 
enriched for quiescent/dormant HSCs (Arai et al., 2004; Nilsson et al., 2005; Winkler 
et al., 2010). Endosteal vessels and their associated perivascular cells are also 
important components of these quiescent BM niches. Particularly, the recently 
described TZ-vessels have been restricted to endosteal/growth plate areas, in which 
we detected the sympathetic cholinergic innervation. In addition, TZ vessels and 
arterioles are surrounded by Nes-GFPhi perivascular BMSCs, which have been 
reported to regulate HSC quiescence (Kunisaki et al., 2013). All these evidences 
led us to study whether Nes-GFPhi BMSCs are a target population of modulated by 
sympathetic cholinergic fibres. 
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Figure 25. Cxcl12 expression is decreased in endosteal Nes-GFPhi cells in 
Gfra2-/- mice. A, Cxcl12 mRNA expression (qPCR) in endosteal and non-endosteal 
BM Nes-GFP+/- BMSCs from Nes-gfp;Gfra2-/- and control Nes-gfp;Gfra2+/- mice. B, 
Cxcl12 mRNA expression (qPCR) in Nes-GFPhi/lo BMSCs from Nes-gfp;Gfra2-/- and 
control Nes-gfp;Gfra2+/- mice. Data are means ± SEM; n and p values are indicated. 
One-way ANOVA and Bonferroni comparisons. * p < 0.05; ** p < 0.01; *** p < 0.001. 
We found that Nes-GFPhi cells were closely associated with the bone and innervated 
by VAChT+ cholinergic fibres (Fig. 14 and Fig. 24). We also detected a 2.5 fold 
increase in Cxcl12 mRNA expression in bone associated Nes-GFP+ cells of Gfra2-
/- mice compared to Nes-GFP+ cells isolated from the flushed marrow. Interestingly, 
Cxcl12 mRNA expression was decreased in endosteal Nes-GFP+ cells in Gfra2-/- 
mice. The decrease in Cxcl12 expression was shown to be specific for Nes-GFPhi 
BMSCs (Fig. 25). 
To resolve the mechanism underlying the innervation of BMSCs by cholinergic 
sympathetic fibres in more detail, we first analysed the expression of acetylcholine 
receptors in different BM stromal populations. Broad expression of several 
acetylcholine receptors was detected in different BM stromal cell lines (Fig. 26A). 
To study whether cholinergic signals can directly trigger a Cxcl12 response, we 
treated different murine stromal cell lines with cholinergic agonists in vitro (Fig. 7). 
The stromal cell line MS-5 produced the highest Cxcl12 level compared to 
osteoblastic cell line MC3T3-E1 and osteocytic cell line MLO-Y4 (Fig. 26B-D). Both 
acetylcholine (ach) and nicotine strongly increased Cxcl12 release by MS-5 cells, 
while the muscarinic receptor antagonist atropine had no effects on Cxcl12 level 
(Fig. 26B). Thus, cholinergic fibre-dependent Cxcl12 induction seems to be 
mediated by direct nicotinic receptor signalling. Along the same lines, Chrna7 mRNA 
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expression was upregulated in Nes-GFP+ BMSCs ((Mendez-Ferrer, Michurina, et 
al., 2010) and Fig. 26D). 
 
Figure 26. Cholinergic signals induce Cxcl12 production. A, Expression 
(mRNA) of cholinergic nicotinic and muscarinic receptors in ST-2, MS-5, MC3T3, 
MLO-Y4 murine stromal cell lines and primary murine osteoclasts. B-D, Cxcl12 
secretion by MS-5 (B), MC3T3 (C) and MLO-Y4 (D) BMSCs treated for 24h with 
nicotine, acetylcholine (ach) (10 µM) or vehicle. MS-5 cells were also pre-treated 
with the muscarinic antagonist atropine (10µM). E, Chrna7 mRNA expression 
(qPCR) in sorted Nes-GFP+/- BMSCs. F, Cxcl12 secretion in primary BM cultures 
derived from mice with the indicated genotype. B-F, Data are means ± SEM; n and 
p values are indicated. One-way ANOVA and Bonferroni comparisons. * p < 0.05; 
** p < 0.01; *** p < 0.001. 
Additionally, we used BM myeloid primary cultures to confirm the direct link between 
cholinergic stimulation and Cxcl12 production. While Cxcl12 secretion was normal 
in BM of WT and Adrb3-/- mice, cholinergic fibre-deficient Gfra2-/- mice and mice 
lacking the α7 cholinergic receptor (Chrna7-/-) showed a 5-fold reduction of BM 
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Cxcl12 levels (Fig. 26E). In conclusion, these results demonstrate that cholinergic 
fibres can directly induce Cxcl12 expression by activating Chrnα7 receptor in 
endosteal Nes-GFPhi BMSCs. 
4.11 Sympathetic cholinergic nerve fibres regulate HSC 
quiescence in endosteal BM niches 
Although the vast majority of HSCs are located around perisinusoidal niches in the 
central bone marrow (Acar et al., 2015), a small subset of quiescent HSCs have 
been found enriched in endosteal niches. According to this, we found that the 
frequency of quiescent HSPCs (arrested in G0) was significantly higher in endosteal 
BM compared to non-endosteal flushed BM (Fig. 27A). However, this normal 
distribution was disrupted in Gfra2-/- mice. Specifically, the percentage of quiescent 
HSPCs was dramatically reduced in the endosteal compartment while unaltered in 
the non-endosteal environment, suggesting that HSPC quiescence could be 
compromised in Gfra2-/- BM endosteal niches. Unlike the HSPC trafficking defect 
(Fig. 11F), the reduced frequency of quiescent endosteal HSPCs in Gfra2-/- mice 
was not corrected by abrogating β-adrenergic signalling (Fig. 27A-B). Interestingly, 
when cell cycle analysis was performed in Chrna7-/- mice a similar disruption was 
observed in normal distribution of quiescent HSPCs, indicating that endosteal HSC 
quiescence is controlled by α7 cholinergic receptor signalling (Fig. 27C). These 
results highlight sympathetic cholinergic fibres, rather than sympathetic 
noradrenergic fibres, as putative regulators of HSC quiescence in endosteal niches. 
Then, different HSC functions, such as migration and quiescence, are differentially 
regulated by noradrenergic and cholinergic signals in separate BM niches. 
Although endosteal quiescent HSCs only represent a minority of the whole HSC 
population, their biological relevance for haematopoiesis seems high under 
stress/regenerative paradigms. Quiescent or dormant HSCs have been proposed 
to remain protected in endosteal compartments until activation in stress situations 
(i.e irradiation) to contribute to the replenishment of the haematopoietic system 
(Trumpp et al., 2010). To study the role of cholinergic HSC quiescence signals in 
contributing to stress-induced haematopoiesis we investigated the HSC response 
to myelosupressive stress induced by 5-fluoruracil (5-FU) treatment. 5-FU is a 
pyrimidine analog which blocks DNA synthesis and thus depletes actively cycling 
HSPCs (in G2/S/M phase). Consistent with the increased fraction of endosteal 
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HSCs in the G1 phase of the cell cycle, Gfra2-/- mice exhibited an accelerated 
haematopoietic recovery from myelotoxic injury triggered by 5-FU. A similarly 
improved recovery from myelotoxic stress was observed in Chrna7-/- mice (Fig. 
27D). 
 
Figure 27. Endosteal quiescent HSCs are activated in Gfra2-/- mice. A, 
Distribution of G0 (green), G1 (orange) and G2/S/M (purple) cell cycle phases in 
HSCs isolated from endosteal (e) and non-endosteal (n-e) BM from C57Bl/6J mice, 
Gfra2-/- mice and Gfra2-/-;Adrb3-/-. B, Representative plots of cell cycle analysis in 
HSPCs. Cell cycle distribution, determined by PY/H42 staining, of LIN-
SCA1+cKIT+FLT3- HSCs isolated from endosteal (bone) and non-endosteal 
(marrow) BM fractions of Gfra2-/- and Gfra2+/+ mice. The frequencies of the gated 
populations are indicated. C, Distribution of cell cycle phases in HSCs isolated from 
Chrna7-/- mice. D, Haematopoietic recovery after myeloablation with 5-FU (150 
mg/kg). Circulating WBCs before and 30 days after 5-FU treatment of Gfra2-/-, 
Chrna7-/- and control mice. A, C-D, Data are means ± SEM; n and p values are 
indicated. A,C, One-way ANOVA and Bonferroni comparisons. D, Multiple two-tailed 
test. * p < 0.05; ** p < 0.01; *** p < 0.001. 
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Figure 28. Cholinergic fibre deficiency deregulates endosteal HSCs. Gene set 
enrichment analysis (GSEA) of gene sets previously linked to self-renewing or 
mobilised HSCs in LIN-SCA1+cKIT+CD150+CD48-CD41- cells isolated from 
endosteal (end) or non-endosteal (non-end) BM from control Gfra2+/+ or Gfra2-/- 
mice. FDR, False discovery rate. Significantly changed gene sets (FDR<0.25) are 
labelled in red (up-regulated) and green (down-regulated). Normalized enrichment 
scores (NES) are indicated.  
Decrease self-renewal capacity can be a possible physiological consequence of 
abnormal HSC proliferation in Gfra2-/- mice. To study potential alterations in the HSC 
self-renewal program we analysed the transcriptomic profile HSCs isolated from 
endosteal and non-endosteal BM of Gfra2-/- and control mice by RNASeq. 
Taking advantage of the gene set enrichment analysis (GSEA) tool, we compared 
our differentially expressed genes with published gene sets which have been 
reported to be enriched in self-renewing or mobilised HSCs. In line with the 
increased quiescence of endosteal HSCs, GSEA revealed an up-regulation of long-
term HSC specific genes (Forsberg et al., 2010), the HSC “fingerprint” (Chambers 
et al., 2007) and genes highly expressed in self-renewing HSCs (Krivtsov et al., 
2006) in endosteal HSCs (compared with non-endosteal HSCs). Similarly, genes 
expressed at a low level in self-renewing HSCs (Krivtsov et al., 2006) and highly 
enriched in mobilised HSCs (Forsberg et al., 2010) were found to be down-regulated 
in endosteal HSCs (Fig. 28) 
In general these gene sets were unchanged when comparing non-endosteal HSCs 
from control and Gfra2-/- mice. However, important differences were revealed 
between endosteal HSCs from control and Gfra2-/- mice. Long-term HSC-specific 
genes, the HSC “fingerprint” and genes highly expressed in self-renewing HSCs 
were down-regulated in endosteal HSCs isolated from Gfra2-/- mice (Fig. 28). 
Overall, the RNAseq data analysis supports the concept of a cholinergic signalling-
dependent regulation of HSPC quiescence in the endosteal BM compartment. Lack 
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of cholinergic innervation in the Gfra2-/- model results in abnormal activation of 
quiescent HSCs in endosteal niches. 
 
Figure 29. Cholinergic innervation contributes to long-term HSC maintenance 
and function in endosteal BM niches. A, Distribution of G0 (green), G1 (orange) 
and G2/S/M (purple) cell cycle phases in CD45.2+ HSCs isolated from lethally-
irradiated CD45.1 C57Bl/6J mice transplanted with endosteal or non-endosteal BM 
from Gfra2+/- or Gfra2-/- mice. B, Circulating CD45.2+ donor-derived haematopoietic 
cells 24 weeks after transplantation. Donor cells were mixed with 106 CD45.1+ 
competitor BM cells. Data are means ± SEM; n and p values are indicated. One-
way ANOVA and Bonferroni comparisons. * p < 0.05. 
To study the functional relevance of decreased HSC quiescence and self-renewal 
in endosteal Gfra2-/- BM, we performed competitive long-term repopulation assays 
using endosteal and non-endosteal BM cells from Gfra2-/-  and control Gfra2+/- mice.  
In these experiments donor cells were mixed with supporting CD45.1 
haematopoietic cells to assess long-term HSC maintenance in WT recipients. The 
analysis of recipient mice was performed 24 weeks after transplantation. 
Surprisingly, the frequency of quiescent HSCs was still higher in those mice 
transplanted with endosteal BM (Fig. 29A), although mice transplanted with non-
endosteal BM showed a better haematopoietic reconstitution (Fig. 29B). These 
results could suggest that even 6 months after transplantation endosteal HSCs 
could keep quiescent, while non-endosteal HSCs would be responsible for the 
replenishment of the haematopoietic system. Further transplants are under current 
investigation to clarify this. In any case, those recipient mice transplanted with 
endosteal BM from Gfra2-/- mice showed significantly reduced haematopoietic 
reconstitution 24 weeks after transplantation (Fig. 29B).  
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Since HSC quiescence is required for long-term HSC self-renewal, these results 
suggest that sympathetic cholinergic fibres promote HSC quiescence and long-term 
maintenance in endosteal niches. 
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“Yin and yang, male and female, strong and weak,  
rigid and tender, heaven an earth, light and darkness, 
 thunder and lightning, cold and warmth, good and evil…  
The interplay of opposite principles constitutes the universe” 
Confucius 
 
 
 
 Discussion 
 
 
83 
 
5 Discussion 
The complexity of BM niches appreciated over the past few years challenges our 
complete dissection of the functional relationships between BMSCs and HSCs. 
Despite intense debate and a tendency to exacerbate new markers and relatively 
small differences across studies, these efforts have allowed for significant 
conceptual refinements. Now, the existence of distinct BM niches harbouring 
different HSCs/HSC states is becoming the predominant idea. Current 
investigations in this field are trying to understand how such different spatially-
separated BM niches can be regulated in a coordinated manner to ensure 
physiological haematopoiesis (Morrison & Scadden, 2014). 
At the same time, the ANS is a master regulator of peripheral organ function 
controlling the fine-tuning of multiple physiological processes. In this context several 
studies in the last decade have shown how sympathetic innervation in the BM 
contributes to HSC niche regulation. On one hand, sympathetic fibres and their 
associated Schwann cells directly regulate HSC quiescence/proliferation via β2-
adrenergic receptor and Tgf-β signalling, respectively (Maestroni et al., 1997; 
Spiegel et al., 2007; S. Yamazaki et al., 2011). On the other hand, the SNS targets 
osteoblasts and BMSCs to modulate HSC functions indirectly via β2- and β3-
adrenergic receptors (Katayama et al., 2006; Mendez-Ferrer, Battista, et al., 2010).  
Among these processes, sympathetic control of HSPC circadian trafficking has been 
intensively studied (Mendez-Ferrer et al., 2008; Scheiermann et al., 2012), since the 
stimulation of this physiological trafficking allows for life-saving HSC transplantation 
procedures. These studies also suggested apparently paradoxical messages, such 
as the induction of opposite processes (HSPC egress vs homing) via similar 
sympathetic mechanisms only separated on a temporal scale (day vs night). 
In this study we show for the first time how the ANS uses a postsynaptic 
neurotransmitter different from noradrenaline – acetylcholine – to regulate BM HSC 
niches in a spatiotemporal manner. We have uncovered a dual autonomic 
cholinergic regulation of HSC niches. Firstly, the PNS modulates circadian HSPC 
trafficking through sinusoids antagonising sympathetic noradrenergic signals at the 
end of the night phase. Secondly, sympathetic cholinergic fibres identified in the 
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bone and endosteal niches innervate nestin+ cells to promote HSC quiescence and 
long-term maintenance (Fig. 30). 
 
Figure 30. Model of dual autonomic cholinergic regulation of HSC niches. 
Cholinergic autonomic signals antagonize sympathetic noradrenergic signals at the 
end of the resting period contributing to circadian HSPC and leukocyte trafficking 
through sinusoidal niches. Sympathetic cholinergic fibres activate bone associated 
nestin+ BMSCs, thereby locally regulating HSC quiescence and maintenance in 
endosteal niches. 
5.1 The PNS indirectly regulates circadian HSPC trafficking 
in perisinusoidal niches 
Gfra2-/- mice were initially used in this study as model of peripheral parasympathetic 
deficiency. The absence of Nrtn/Gfrα2 signalling in these mice, which is critical for 
the survival of postganglionic parasympathetic neurons, results in dramatic 
reduction of cholinergic innervation in several ganglia and glands of Gfra2-/- mice 
while leaving sympathetic innervation intact (Rossi et al., 1999). Our data confirmed 
a 7-fold reduction in acetylcholinesterase activity (indirectly measurement of 
parasympathetic tone) in Gfra2-/- mice (Fig. 8A), making this model suitable to 
address the study of parasympathetic regulation of BM HSC niches. 
Although HSPC and haematopoietic cell numbers are normal in the BM of Gfra2-/- 
mice (Fig. 8B-C), an abnormal accumulation of HSPCs and leukocytes was 
observed in the peripheral blood at the beginning of the night phase (Fig. 9). This 
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result suggests that normal circadian traffic of blood cells is disrupted in 
parasympathetic fibre-deficient mice. The other branch of the autonomic nervous 
system, the SNS, is involved in the regulation circadian HSPC trafficking at two 
different time points. Two daily peaks of sympathetic activity have been detected in 
mice: one during the night associated with increased nocturnal activity in mice (De 
Boer & Van der Gugten, 1987; Maestroni et al., 1998), and another following light 
exposure to induce sympathetic efferent activity and suppress parasympathetic tone 
(Niijima, Nagai, Nagai, & Nakagawa, 1992; Terazono et al., 2003). These two daily 
peaks of sympathetic activity are associated with opposite functions of the SNS in 
regulating HSPC trafficking in and out of the BM. 
HSPCs are mainly released into the bloodstream during the day in response to light 
stimuli (Mendez-Ferrer et al., 2008). Postganglionic sympathetic terminals 
innervating the BM release noradrenaline and modulate Cxcl12 expression in 
nestin+ BMSCs via β3-adrenergic receptor signalling. During the night phase, when 
HSPCs and leukocyte preferentially home to the BM, sympathetic signalling 
contributes to their BM recruitment (Scheiermann et al., 2012). In this context, 
specific nocturnal accumulation of circulating HSPCs in the peripheral blood of 
parasympathetic fibre-deficient Gfra2-/- mice suggests that HSPC egress and/or 
homing could be deregulated in this mouse model. However, nocturnal HSPC 
accumulation in the peripheral blood was not related to a decrease in BM homing 
but rather correlated with increased recruitment of HSPCs to the BM of Gfra2-/- mice 
at the same time (Fig. 10). This together with the increased nocturnal noradrenaline 
concentration (Fig. 11A-D) indicates that increased HSPC homing to the BM in 
Gfra2-/- mice could be promoted by an abnormal nocturnal sympathetic tone. In fact, 
considering that the predominant phenotype is HSPC accumulation in peripheral 
blood, we can discard that increased BM homing in Gfra2-/- mice also actually 
contributes to expand the pool of “mobilisable” HSPCs. 
The simultaneous increase of HSPC BM homing and HSPC accumulation in the 
blood of Gfra2-/- mice suggests that HSPC mobilisation is enhanced in this mouse 
model. HSPC circadian egress and mobilisation in response to G-CSF are triggered 
by sympathetic β2- and β3-adrenergic receptor signalling in the BM (Mendez-Ferrer, 
Battista, et al., 2010). Combined genetic deletion of Gfra2 and Adrb2 or Adrb3 
revealed the importance of parasympathetic fibres in specifically dampening 
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sympathetic β3-adrenergic signalling in the BM. Only Gfra2-/- mice also lacking β3-
but not β2-adrenergic signalling recovered normal numbers of circulating HSPCs 
during the nocturnal phase (Fig. 11F-G). While β2-adrenergic-dependent HSPC 
mobilisation has been associated with osteoblastic cells in endosteal niches 
(Katayama et al., 2006), β3-adrenergic receptor-dependent HSPC egress is 
mediated by perisinusoidal nestin+ BMSCs (Mendez-Ferrer et al., 2008). 
Exacerbated sympathetic tone and increased HSPC mobilisation in Gfra2-/- mice 
correlate with reduced BM Cxcl12 level at the same circadian time (Fig. 13), 
highlighting the importance of the PNS in controlling BMSC Cxcl12 production by 
blocking the sympathetic β3-adrenergic axis.  
Overall these results suggest that the PNS contributes to orchestrate physiological 
day/night oscillations of circulating HSPCs and leukocytes by dampening 
sympathetic tone specifically during the night period. Although normal sympathetic 
activity induces HSPC homing to the BM during the nocturnal period (Scheiermann 
et al., 2012), the abnormally high sympathetic signalling in Gfra2-/- mice also induces  
enforced HSPC egress (mobilisation) during this period. Thus, unrepressed SNS 
triggers HSC egress to the bloodstream after light exposure during the day, but 
parasympathetic activation at the beginning of the night period decreases 
sympathetic tone. The low sympathetic tone that remains during the night period 
stimulates nocturnal BM homing. 
How different levels of sympathetic activity cooperate to stimulate opposite 
processes at different circadian times requires further analysis. The expression of 
different types of adrenergic receptors is variable among both haematopoietic cells 
and BMSCs. Furthermore, exposure of β-adrenergic receptors to high levels of their 
ligands could cause rapid desensitization of the adenylyl-cyclase response triggered 
by the receptor. β2-adrenergic receptor has been reported to be quite sensitive to 
receptor desensitization (Lohse, Benovic, Codina, Caron, & Lefkowitz, 1990). A mild 
nocturnal sympathetic tone could induce HSPC homing via β2-adrenergic receptors 
during the night. The strong diurnal sympathetic tone could partially desensitize β2-
adrenergic receptors and promote HSPC egress through more resistant β3-
adrenergic receptors. 
Recently, cholinergic signals originated at central level have been reported to control 
G-CSF-mediated mobilisation in the BM through the glucocorticoid system (Pierce 
 Discussion 
 
 
87 
 
et al., 2017), suggesting that the PNS could also have an impact on enforced HSPC 
trafficking on a central level. Similarly, treatment of mice with blood-brain barrier 
permeable and non-permeable cholinergic antagonists suggested that 
parasympathetic-mediated inhibition of sympathetic activity takes place at the 
central level (Fig. 11E). Central cholinergic signalling might particularly contribute to 
HSPC trafficking during stress situations. 
5.2 Non-cell autonomous HSPC trafficking alteration 
Reciprocal transplantation experiments in Gfra2-/- and control mice exclude any cell-
autonomous role for Gfra2 signalling in HSCs in contributing to the HSPC trafficking 
phenotype (Fig. 12). Although neither Nrtn either Gfrα2 seem to be expressed in 
adult BM haematopoietic cells (Nakayama et al., 1999), FL HSPCs express high 
levels of RET and Gfrα1-3 co-receptors. On the other hand, although GDNF and 
Nrtn bind preferentially to Gfrα1 and Gfrα2 respectively, both co-receptors share 
structural and functional similarities (Baloh et al., 1997; Hoane et al., 1999) so it is 
possible some overlapping between Gfrα1 and Gfrα2 signalling. In any case, RET 
has been shown to be expressed in haematopoietic cells, HSCs, while the 
neurotrophic factors GDNF and Nrtn are enriched in BMSCs (Fonseca-Pereira et 
al., 2014; Nakayama et al., 1999). This is particularly relevant because it is known 
that RET can be activated in cis but also in trans by its co-receptors and ligands 
(Fleming et al., 2015); and this trans signalling could play a role in myeloid 
differentiation (Nakayama et al., 1999). Interestingly, osteoblasts seem to be one of 
the most important source of Nrtn in adult BM. Therefore, Nrtn/Gfrα2 signalling 
between osteoblasts and sympathetic cholinergic fibres in endosteal niches should 
be further analysed. 
5.3 The PNS independently controls HSPC trafficking and 
anabolic bone signalling 
Gfra2-/- mice have been described to be growth-retarded after weaning. This 
phenotype has initially been attributed to malnutrition due to reduced enteric 
innervation in these mice. Bone remodelling and bone formation more specifically 
are very active processes during early stages of life. As cholinergic signalling has 
been described to promote bone anabolic signals (Bajayo et al., 2012; Shi et al., 
2010), parasympathetic deficiency in Gfra2-/- mice could have a relevant impact on 
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skeletogenesis and bone remodelling. Thus, delayed growth of Gfra2-/- mice might 
be caused complementary defects in bone formation as well as malnutrition. 
Along this line, bone µCT showed that Gfra2-/- mice had enlarged cranial sutures 
and decreased trabecular bone. These defects could not be explained by increased 
bone resorption (Fig. 16) and also the number of osteoprogenitor cells was rather 
increased (CFU-F and CFU-OB) than decreased. These results have been 
interpreted has a compensatory response to impaired bone growth in Gfra2-/- mice 
and point out a role of the PNS as positive regulator of bone formation. Indeed, 
osteoprogenitor cell accumulation could suggest a bias towards cell proliferation, 
instead of osteoblastic differentiation. Therefore, it would be important to check if 
the numbers of mature osteoblasts are reduced in Gfra2-/- mice. On the other hand, 
sympathetic denervation in rats has been associated with decreased osteoblastic 
activity and increased resorption activity (Herskovits & Singh, 1984), but this 
intervention would affect all types of innervation, including noradrenergic and 
cholinergic nerve fibres. Along this line, it is known that sympathetic signals control 
both aspects of bone remodelling (decrease bone formation and increase bone 
resorption) downstream of leptin signalling (Elefteriou et al., 2005; Takeda et al., 
2002). 
Neural regulation of bone metabolism is a recent concept and, the expansion of this 
regulation to the BM compartment over the last few years, has given rise to the 
theory of the “brain-bone-blood triad” (Lapidot & Kollet, 2010; Takeda & Karsenty, 
2008). This concept is based on the idea that the interactions between these three 
systems are essential for the regulation of HSPC trafficking. In line with this brain-
bone-blood model, intercellular connections between osteocytes have been 
described as essential for sympathetic fibre-mediated HSPC mobilisation in 
response to G-CSF (Asada et al., 2013). However, in our study G-CSF treatment 
similarly promoted HSPC mobilisation in Gfra2-/- despite the dramatic reduction in 
osteocyte projections (Fig. 17A-B), suggesting that circadian HSPC trafficking 
regulation and bone remodelling are independently regulated in our model. Along 
these lines, acute inhibition of cholinergic signalling in WT mice, which show normal 
bone remodelling, by treatment with cholinergic antagonists stimulated HSPC 
mobilisation, confirming that HSPC mobilisation occurs independently of bone 
remodelling (Fig. 11E).   
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5.4 Local sympathetic cholinergic fibres innervate BM 
endosteal niches 
Whereas the SNS is a key regulator of HSC functions in BM niches, the local 
contribution of possible cholinergic fibres to BM niche regulation has remained 
unexplored. It was previously believed that parasympathetic efferent terminals 
innervating the BM can originate from cranial (projections from the vagus nerve) or 
sacral areas of the spinal cord. So far, only few immunohistochemistry studies have 
reported the presence of scarce fibres close to the bone (Artico et al., 2002; Bajayo 
et al., 2012). Nevertheless, these studies have mostly used immunohistochemistry 
techniques in thin sections. The processing of paraffin sections could expose the 
samples to fixatives and organics dissolvent that could mask or reduce some 
antigens.  As consequence, a physiological role for cholinergic signals in BM niche 
regulation has been remained elusive.  
Taking advantage of ChAT-IRES-cre mouse model and optimized VAChT 
immunofluorescence imaging in whole-mount thick BM sections, we have found 
cholinergic fibres in murine bone proper and endosteal BM (Fig. 18 and 19). 
Interestingly, those fibres were almost absent in Gfra2-/- mice (Fig. 20).  
The two branches of the autonomic nervous system, SNS and PNS, primarily use 
noradrenaline and acetylcholine as postsynaptic neurotransmitters respectively. 
However, exceptions to this general rule have been described. Some embryonic 
sympathetic neurons (i.e. in stellate ganglion) have been identified to exhibit 
cholinergic features, but their frequency gradually diminishes to only ~4% at birth 
(Huang et al., 2013). Likewise, postnatal sympathetic neurons innervating the sweat 
glands and the periosteum can change their neurotransmitter properties and start 
producing acetylcholine (Schutz et al., 2015). Based on their origin and 
neurotransmitter properties, these are sympathetic cholinergic fibres. 
Interestingly, Gfrα2 has been shown to be required for the survival of sympathetic 
cholinergic fibres in the periosteum (Hiltunen & Airaksinen, 2004), which prompted 
us to analyse the origin of the new cholinergic fibres we identified in the bone proper 
and endosteal regions. 
The ‘cholinergic switch’ (Wolinsky & Patterson, 1983) was first characterised in vivo 
in rodents during the first postnatal weeks in sympathetic neurons innervating sweat 
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glands (Guidry & Landis, 1998) and periosteum (Asmus et al., 2000). 
Neurotransmitter change in bone and sweat glands (Habecker & Landis, 1994) 
requires initial noradrenergic activity, ensuing secretion of undefined cholinergic 
differentiation factors, acetylcholine release and maturation of both the target organ 
and its cholinergic innervation. Furthermore, a very recent study has revealed that 
all sacral and pelvic autonomic neurons, which innervate the lower limbs, are 
sympathetic instead of parasympathetic as originally thought (Espinosa-Medina et 
al., 2016). 
Sympathectomy of mice with 6-OHDA during the first postnatal week resulted in 
dramatic reduction of VAChT+ fibres during adulthood, suggesting that endosteal 
and periosteal cholinergic fibres are of sympathetic origin. Along these lines, lineage 
tracing of sympathetic fibres in Th-cre;Ai4D mice, confirmed the sympathetic origin 
if VAChT+ fibres in adult mice (Fig. 22). To sum up, while parasympathetic signals 
indirectly regulate HSPC circadian trafficking by modulating sympathetic activity at 
the central level, cholinergic terminals that innervate the BM locally are of 
sympathetic origin and restricted to endosteal areas. 
  
5.5 Sympathetic cholinergic fibres contribute to postnatal 
BM HSC niche maturation 
As stated before, the full conversion of neurons from noradrenergic to cholinergic 
phenotype in the periosteum takes around 3-4 postnatal weeks in rats (Asmus et 
al., 2000). During this period HSCs are still migrating from the FL to colonize the 
immature BM (Wolber et al., 2002; Zanjani, Ascensao, & Tavassoli, 1993) and 
diminish their proliferative features to acquire a more quiescent phenotype. Both 
processes have been shown to be Cxcl12-dependent (Nagasawa et al., 1996). The 
temporal coordination of the cholinergic switch and HSC quiescence induction 
prompted us to study whether the neurotransmitter switch directly affects Cxcl12-
induced HSC quiescence. Although HSC numbers were not affected in the FL 
before the birth, they were significantly reduced in BM one week after birth. 
Moreover, Cxcl12 gene expression was reduced at P7, pointing toward the lack of 
the main HSC chemoattractant as the cause of reduced BM colonisation by HSCs. 
These results suggest that the appearance of sympathetic cholinergic fibres in 
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endosteal areas and the subsequent up-regulation of Cxcl12 might control two 
important end-stage changes – BM colonisation and induction of HSC quiescence - 
in developmental haematopoiesis. Neural crest-derived nestin+ BMSCs play an 
important role as mediators of Cxcl12-dependent HSC migration to the BM (Isern et 
al., 2014). Endosteal sympathetic cholinergic fibres could therefore target these 
nestin+ BMSCs thereby helping to establish HSC niches by secreting Cxcl12. In 
conclusion, endosteal sympathetic cholinergic fibres might be important control 
element of developmental haematopoiesis. 
Although it is known that the cholinergic switch in sympathetic neurons is 
retrogradely specified by periosteum-derived secreted factors, it remains 
controversial the identity of these factors (Asmus et al., 2000). The leukemic 
inhibitory factor (LIF) and CNTF were initially proposed, but mice lacking CNTF, LIF 
or both exhibit normal sympathetic cholinergic fibres (Francis, Asmus, & Landis, 
1997; Landis, 1996). Interestingly, triple knock-out mice of CNTF. LIF and another 
neurotrophic factor called cardiotrophin-1 (CT-1) show significant motoneuron 
(cholinergic fibre) cell loss and functional deficits very early during postnatal, 
pointing out CT-1 as another possible mediator of cholinergic switch. Then, it would 
be interesting to check if this triple knock-out model shows similar HSPC and Cxcl12 
reductions than to Gfra2-/- mice early postnatally 
5.6 The master HSC regulator Cxcl12 controls different 
HSC functions in separated BM niches 
We found endosteal sympathetic cholinergic fibres in close contact with nestin-
GFPhi cells in adult endosteal BM and Nes-GFPhi periarteriolar BMSCs have been 
described to regulate HSC quiescence (Kunisaki et al., 2013). These observation 
identify Nes-GFPhi cells as interesting candidates to mediate sympathetic 
cholinergic signals. Indeed, we report here that Nes-GFPhi cells are enriched in the 
endosteal compartment (Fig. 14B-C) and express higher level of Cxcl12 compared 
to sinusoidal Nes-GFPlo cells (Fig. 25). Interestingly, the reduction in quiescent 
HSCs in both Gfra2-/- and Chrna7-/- mice was accompanied with endosteal-specific 
Cxcl12 down-regulation in Nes-GFPhi BMSCs (Fig. 25). In addition, nicotine 
treatment induces Cxcl12 secretion in in vitro BM stromal cell lines and primary 
myeloid cell cultures and Gfra2-/- and Chrna7-/- mice (but not Adrb3-/- mice) release 
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less Cxcl12 compared to control mice (Fig. 26). This data strongly suggests that 
sympathetic cholinergic fibres innervate endosteal Nes-GFPhi cells to up-regulate 
Cxcl12 expression and thus induce HSPC quiescence. Thus, HSC trafficking and 
quiescence are differentially regulated by sympathetic noradrenergic and 
sympathetic cholinergic nerve fibres in separate compartments. 
Although our data indicates that different HSC functions like migration/retention and 
quiescence might be regulated by different nerve fibres in spatially-separated BM 
niches, both types of regulations seem to converge in Cxcl12 level modulation. 
Since its discovery (Nagasawa et al. 1996), Cxcl12 deregulation in the BM has been 
associated with multiple types of BM niche disorders. However, it is still unclear how 
Cxcl12 and other HSC maintenance factors like Scf differentially regulate HSC 
functions. In our study, we have found a dual cholinergic signalling which controls 
HSPC trafficking and quiescence in separate BM compartments by modulating 
Cxcl12 level.  
Current opinions in the field highlight the importance of different cellular sources of 
HSC chemoattractant cytokines for determining their effects on HSC regulation. 
Recently, Cxcl12 deletion in periarteriolar NG2+Nes-GFPhi BMSCs has been 
proposed to reduce HSC numbers and delocalize HSC in the BM. NG2+Nes-GFPhi 
BMSCs have therefore been suggested as major Cxcl12 source responsible for 
HSC localization in different BM niches (Kunisaki et al., 2013). In contrast, 
Lepr+Nes-GFPlo BMSCs-derived Scf is especially important to maintain BM HSC 
numbers (Ding et al., 2012). In any case, both Cxcl12 as well as Scf are required in 
the different BM niches since their deletion in all Nes-GFP+ BMSCs depleted BM 
HSCs in a similar manner (Asada et al., 2017). 
In our study we have provided evidence suggesting that parasympathetic indirect 
regulation of HSPC trafficking is mediated by perisinusoidal Nes-GFPlo BMSCs. In 
contrast, endosteal sympathetic cholinergic innervation targets endosteal Nes-
GFPhi BMSCs to HSC quiescence. In addition, we show that both nestin+ 
populations exhibited different properties: while Nes-GFPlo cells are more abundant 
and express lower Cxcl12 level, Nes-GFPhi are rare (mostly restricted to arterioles 
and TZ vessels in endosteal niches) and express higher Cxcl12 level. 
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The Cxcl12 decrease associated with increased HSPC trafficking in Gfra2-/- mice 
most likely results from a reduction in Nes-GFPlo BMSCs in perisinusoidal niches 
(Fig. 14C). Indeed, Cxcl12 expression in non-endosteal nestin+ cells and Nes-GFPlo 
cells were not affected Gfra2-/- mice, supporting a HSPC trafficking phenotype that 
is caused by reduction of central Nes-GFPlo cell numbers. On the contrary, 
sympathetic cholinergic fibres directly target Cxcl12 expression in endosteal Nes-
GFPhi BMSCs rather than affecting their numbers in endosteal niches (Fig. 25). 
In summary, this work constitutes a significant example of how different HSC 
functions can be controlled by the same HSC chemoattractant factor in different 
spatiotemporal contexts. 
5.7 Dynamic interactions between noradrenergic and 
cholinergic signalling 
Although our data strongly argues for a spatial segregation of noradrenergic and 
cholinergic neuro-immune junctions in separate BM compartments, we cannot 
exclude the possibility that some nerve fibres might have mixed and/or highly 
dynamic properties.  
The sympathetic superior cervical ganglion contains neurons with combined 
noradrenergic and cholinergic properties (Furshpan, Landis, Matsumoto, & Potter, 
1986; Landis, 1976) and different neurotrophic factors can rapidly affect 
neurotransmitter synthesis, storage, release and uptake (Luther & Birren, 2009; 
Yang, Slonimsky, & Birren, 2002). Therefore, although our data suggest that 
parasympathetic-sympathetic interactions that coordinate circadian HSPC 
trafficking take place at CNS, we cannot exclude the possibility of a peripheral 
regulation. Using both Th-cre;Ai4D and Dhh-cre;Ai4D models, we have found that 
sympathetic cholinergic VAChT+ fibres and sympathetic noradrenergic TH+ fibres 
were closely associated in periosteal regions, suggesting that feedback loops could 
take place between these two types of innervation near the BM (Fig. 22).  In fact, 
potential postsynaptic inhibitory feedback loops between the two branches of the 
ANS have been commonly observed in other systems. For instance, it has been 
shown that the PNS attenuates sympathetic activation of the pancreas in dogs 
(Benthem et al., 2001). Similarly, prejunctional cholinergic fibres in rat periorbital 
smooth muscle depress noradrenaline release through muscarinic receptors 
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expressed in sympathetic nerve fibres (Beauregard & Smith, 1994). Likewise, 
acetylcholine endogenously released from pulmonary parasympathetic nerves in 
guinea pigs can block neural transmission in the adjacent sympathetic nerves via 
activation of prejunctional muscarinic heteroreceptors (Pendry & Maclagan, 1991). 
Modulation of sympathetic activity by parasympathetic signalling has been studied 
in depth in the heart. In this system, parasympathetic activation decreases the heart 
rate by directly targeting sympathetic signalling under normal and pathological 
conditions (Azevedo & Parker, 1999; Buchholz et al., 2015; Gavioli et al., 2014; 
Miyashita et al., 1999). On the contrary, parasympathetic activity can also be 
repressed by sympathetic fibres (Smith-White, Wallace, & Potter, 1999). Moreover, 
synthesis of nerve growth factor, which is essential for the survival of sympathetic 
noradrenergic terminals, by neurons of the parasympathetic cardiac ganglion is 
regulated by β-adrenergic signals (Hasan & Smith, 2014). These observations 
demonstrate the importance of feed-back loops between both branches of the 
autonomic nervous system to control survival of PNS and SNS fibres, but also reveal 
a potential mechanism by which two important HSC functions like trafficking and 
quiescence could be precisely coordinated. Thus, local postsynaptic inhibitory 
feedback loops might be also placed in endosteal niches to fine-tune the neural 
regulation of haematopoiesis in relation to demands of the organism. 
5.8 Target populations of sympathetic cholinergic fibres in 
endosteal BM niches 
In line with previous studies (Acar et al., 2015), we show that more than 85% of 
HSCs are located in the central part of the BM (non-endosteal compartment) 
occupying perisinusoidal niches. This finding is not surprising as the central marrow 
represents over 90% of the inner volume of the long bones. However, in this study 
describe that sympathetic cholinergic fibres present exclusively in endosteal BM 
regulate a small subset of quiescent HSCs. This novel finding is consistent with 
previous studies suggesting that the endosteal environment promotes HSC 
quiescence and self-renewal (Arai et al., 2004; Calvi et al., 2003; Itkin et al., 2016; 
Kunisaki et al., 2013; Nilsson et al., 2005; Stier et al., 2005; Zhang et al., 2003). 
In this context, we have identified Nes-GFPhi BMSCs as putative target cells of 
cholinergic signalling in the endosteal compartment. This population has been 
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recently associated to endosteal arterioles named TZ vessels (Itkin et al., 2016; 
Kusumbe et al., 2014). Because their location in endosteal niches, TZ vessels might 
be functionally different from other arterioles which are located in the central part of 
the marrow and also surrounded by Nes-GFPhi BMSCs (Kunisaki et al., 2013). 
Indeed, it has been proposed that these low-permeable endosteal arterioles form 
an osteo-vascular niche where low active HSCs are influenced by both endosteal 
and vascular elements supporting HSC maintenance (Itkin et al., 2016). Thus, we 
hypothesize that TZ vessels might play a relevant role in relaying local cholinergic 
signalling in the BM. According to this, we report that Nes-GFP+ cells express higher 
level of Chrna7 gene expression compared to other stromal cells. Interestingly, 
expression of this receptor is even more up-regulated in Gfra2-/- Nes-GFP+ cells, 
suggesting a potential compensatory mechanism by which these BMSCs up-
regulate cholinergic receptors in absence of cholinergic signals (Fig. 26C). These 
results support the emerging concept of distinct BM vessels in differentially 
regulating haematopoiesis (Itkin et al., 2016). 
Although we identified endosteal Nes-GFPhi cells as target population of cholinergic 
signalling, we cannot exclude the possibility that endosteal cholinergic signalling 
might target other BMSC or stromal populations. G-CSF-induced sympathetic 
noradrenergic signalling induces osteoblast suppression and HSPC activation 
through down-regulation of Cxcl12 (Katayama et al., 2006). G-CSF treatment also 
depletes a population of trophic endosteal macrophages that support osteoblast 
function (osteomacs), suggesting that these macrophages could also be supressed 
by noradrenergic signalling. The influence of sympathetic cholinergic signalling on 
these other endosteal populations remains to be investigated. Alternatively, 
although less likely, a direct effect of cholinergic signalling on HSPCs cannot be 
excluded. Some studies have proposed the expression of cholinergic nicotinic 
receptors in HSPCs (Chang et al., 2010). Specifically, Chrnα7 identifies a HSPC 
population with an important role during regulation of inflammation (Gahring et al., 
2013). Future experiments should aim at comparatively studying cholinergic 
receptor expression in endosteal versus non-endosteal HSPCs. 
In summary, in this study we have presented evidence suggesting that endosteal 
BM niches are modulated by cholinergic signalling, identifying Nes-GFPhi BMSCs 
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as one possible target population. Further studies will clarify which other populations 
can also be regulated and how this affects to HSC function. 
5.9 Sympathetic cholinergic fibres regulate HSC self-
renewal and long-term maintenance in endosteal BM niches 
Transcriptomic analysis of HSPC from endosteal and non-endosteal HSPCs 
confirmed intrinsic differences between these populations. Comparing their 
transcriptomic profile with previously published gene sets shows increased self-
renewal and anti-mobilising capacity of endosteal compared to non-endosteal HSCs 
(Fig. 28). 
Importantly, the lack of sympathetic cholinergic innervations has a huge impact on 
the gene expression profile of endosteal HSCs from Gfra2-/- mice. Long-term HSC 
specific genes and self-renewal-associated genes are down-regulated in cholinergic 
fibre-deficient mice, while genes associated to HSC mobilisation are up-regulated 
(Fig. 28). These results suggest an abnormal over-activation of dormant HSCs in 
the endosteal compartment of Gfra2-/- mice, which independently confirms the 
increased activation of these cells as measured by PY/H42 assay. 
Some authors have proposed that endosteal quiescent HSCs provide a HSC 
backup to restore normal haematopoiesis in emergency (Wilson et al., 2008). Along 
these lines, Gfra2-/- mice exhibit an accelerated short-term haematopoietic recovery 
after myelosupressive therapy (Fig. 27D), while long-term repopulation capacity 
after transplantation was significantly reduced (Fig. 29).  
But quiescence is not only important to ensure the self-renewal and long-term 
repopulation activity of HSCs (Cheng et al., 2000), cell cycle regulation is also critical 
to determine HSC fate (Pelayo et al., 2006; Walkley et al., 2007). In fact, there is 
evidence suggesting that disruption of endosteal niches induces HSC proliferation 
and mobilisation to perisinusoidal niches as intermediate step preceding egress to 
extramedullary sites (Visnjic et al., 2004). These observations imply that disruption 
of cholinergic signalling in endosteal BM niches might not only cause an increase in 
HSC proliferation but also a transition to sinusoidal areas. Furthermore, some 
studies have suggested that differentiation into certain haematopoietic lineages can 
be associated to certain sub-localizations in the BM (Cordeiro Gomes et al., 2016). 
Endosteal niches have been reported to harbour and regulate differentiation of early 
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lymphoid progenitors (Ding & Morrison, 2013; Morrison & Scadden, 2014). Future 
experiments should explore a possible involvement of cholinergic signalling as 
modulator of lymphoid differentiation. 
5.10 Sympathetic noradrenergic vs sympathetic 
cholinergic: antagonistic regulation HSC functions in the BM 
This study shows that a stress-response system, such as the SNS, can trigger 
sinusoidal transmigration of activated HSCs, but at the same time protect the HSC 
pool from exhaustion by inducing quiescence of a smaller subset of HSCs. This 
paradoxical situation is possible using different neurotransmitters. While HSPC 
transmigration in perisinusoidal niches is governed by noradrenergic signalling, 
acetylcholine released by sympathetic cholinergic fibres contribute to maintain HSC 
quiescence in endosteal niches.  
This complex regulation might allow for fine-tuned HSC regulation and efficient 
response to stress, since the SNS does not only activate and mobilise stem cells in 
one compartment, but it also prevents stem cell attrition by inducing quiescence in 
a comparatively smaller compartment. This dual cholinergic regulation could be 
particularly important in the inflammatory/disease context. The SNS is key triggering 
pro-inflammatory effects in the early phases, but also in the later stages to inducing 
anti-inflammatory mechanisms to resolve the inflammatory process (Pongratz & 
Straub, 2014). At early stages, sympathetic cholinergic innervation could contribute 
to protect endosteal dormant HSCs from exhaustion while most HSCs get activated 
and mobilised. Later at later stages, parasympathetic signalling might coordinate 
sympathetic activity to shut down HSC mobilisation. Further studies should clarify 
the importance of cholinergic regulation of BM HSC niches in pathological 
conditions. 
 
In summary, this is one of the first examples of how both branches of the autonomic 
nervous system cooperate to carry out a coordinated regulation of antagonistic HSC 
functions through noradrenergic sympathetic and cholinergic sympathetic signalling 
in spatially separated BM niches. And by extent, reveals how different signals from 
the autonomic nervous system regulate adult stem cells to meet distinct 
spatiotemporal physiological demands. 
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6 Conclusions 
The results presented in this study lead to the following conclusions: 
 The parasympathetic nervous system indirectly contributes to the circadian 
regulation of HSC trafficking between the BM and peripheral blood. 
 
 The activity of the parasympathetic nervous system is triggered at the end of 
the resting phase (end of the day in the murine model before the start of the 
active nocturnal phase) and counterbalances sympathetic-induced HSC 
egress at night (in mice), when BM homing becomes predominant. 
 
 The parasympathetic nervous system modulates sympathetic activity at the 
central level, which results in downregulation of β-adrenergic receptor 
signalling in BMSCs, leading to increased Cxcl12 expression.  
 
 The cholinergic regulation of the BM might not only affect haematopoiesis but 
it might also impact bone remodelling. 
 
 The BM endosteal compartment (close to the bone) is innervated by some 
sympathetic fibres, which switch their neurotransmitter properties postnatally 
and release acetylcholine, instead of noradrenaline (becoming sympathetic 
cholinergic fibres). 
 
 Sympathetic cholinergic fibres induce Cxcl12 expression and promote 
postnatal BM colonisation by HSCs, and possibly HSC quiescence. 
Therefore, the cholinergic switch seems to contribute to the BM HSC niche 
maturation during postnatal development. 
 
 In adulthood, sympathetic cholinergic fibres target nestin+ BMSCs in 
endosteal compartments and induce Cxcl12 expression in these cells via 
nicotinic cholinergic signalling. 
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 Local cholinergic signalling in endosteal BM niches promotes HSC
quiescence and long-term maintenance in a small subset of dormant HSCs
allocated to this compartment.
 Both branches of the autonomic nervous system (parasympathetic and
sympathetic) cooperate to regulate different HSC functions in spatially
separated BM compartments. On the one hand, central cholinergic signalling
modulates sympathetic noradrenergic tone to regulate HSC trafficking in the
central part of the marrow. On the other hand, a sympathetic cholinergic
innervation restricted to endosteal areas promote HSC maintenance and
quiescence in a minor population of dormant HSC.
 This is one of the first examples of a stress-response system (the
sympathetic nervous system) that can simultaneously promote two opposing
processes (stem cell activation-migration and quiescence-maintenance) in
two different niches. This might allow stem cells to efficiently respond to
stress but simultaneously prevent stem cell attrition.
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7 Conclusiones 
Los resultados de este estudio permiten extraer las siguientes conclusiones: 
 El sistema nervioso parasimpático contribuye a la regulación circadiana del 
tráfico de células madre hematopoyéticas entre la médula ósea y el torrente 
sanguíneo. 
 
 La actuación del sistema nervioso parasimpático al final de la fase de reposo 
(fase diurna en el modelo murino, en contraposición a la fase de actividad 
nocturna) permite la inhibición del sistema nervioso simpático durante la 
noche y disminuye la salida de las células madre hematopoyéticas a la 
sangre cuando el proceso de “homing” hacia la médula ósea es 
predominante. 
 
 El sistema nervioso parasimpático modula la actividad simpática a nivel 
central y, al igual que la contribución simpática durante la fase diurna, es 
transmitida a las células estromales del microambiente de la médula ósea a 
través de los receptores adrenérgicos β y la disminución de los niveles de 
Cxcl12. 
 
 La regulación colinérgica de la médula ósea podría no limitarse a la 
hematopoyesis, sino también ejercer una función en el remodelado óseo. 
 
 El compartimento endosteal de la médula ósea (próximo al hueso) está 
inervado por fibras simpáticas que cambian sus propiedades 
neurosecretoras en estadios postnatales, cuando cambian la noradrenalina 
por acetilcolina como neurotransmisor postsináptico (convirtiéndose así en 
fibras simpáticas colinérgicas). 
 
 Las fibras simpáticas colinérgicas estimulan la producción de Cxcl12 y la 
colonización de la médula ósea postnatal por parte de las células madre 
hematopoyéticas (cuya proliferación podrían inhibir mediante mecanismos 
similares). De este modo el cambio colnérgico parece estar implicado en la 
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maduración del nicho de células madre en la médula durante el desarrollo 
postnatal. 
 En el estadío adulto, las fibras simpáticas colinérgicas inervan las células
estromales nestina+ presentes en el compartimento endostial e inducen la
expresión de Cxcl12 a través de la señalización colinérgica nicotínica en
estas células.
 La señalización colinérgica local en en endostio promueve la quiescencia y
mantenimiento a largo plazo de un pequeño grupo de células madre
hematopoyéticas localizadas en este nicho.
 Las dos ramas del sistema nervioso autónomo (simpático y parasimpático) 
cooperan entre sí para regular distintas funciones de las células madre 
hematopoyéticas en distintos compartimentos de la médula ósea. Por un 
lado, la señalización colinérgica central modula el tono simpático 
noradrenergico para controlar el tráfico circadiano de células madre 
hematopoyéticas activas a través de los sinusoides. Por otro lado, la 
inervación simpática colinérgica restringida al compartimento endostial 
promueve el mantenimiento y la quiescencia de un grupo de células madres 
hematopoyéticas inactivas. Este es uno de los primeros ejemplos de un 
sistema de respuesta a estrés (el sistema nervioso simpático) capaz de 
promover dos procesos opuestos de manera simultánea: estimular la 
activación y migración de las células madre en un nicho, y simultáneamente 
promover la quiescencia y el mantenimiento del mismo tipo de células 
madres en otro nicho. Esto podría permitir a las células troncales responder 
a situaciones de estrés de modo eficiente, mientras se impide que se agote 
la reserva de células madre.
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